Frequencies for first 10,000 rows of pt variable in reac2007q2 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 13 0.13 0.13 ABDOMINAL ADHESIONS | 1 0.01 0.14 ABDOMINAL DISCOMFORT | 8 0.08 0.22 ABDOMINAL DISTENSION | 17 0.17 0.39 ABDOMINAL HAEMATOMA | 2 0.02 0.41 ABDOMINAL PAIN | 44 0.44 0.85 ABDOMINAL PAIN LOWER | 3 0.03 0.88 ABDOMINAL PAIN UPPER | 18 0.18 1.06 ABDOMINAL SYMPTOM | 2 0.02 1.08 ABDOMINAL TENDERNESS | 1 0.01 1.09 ABDOMINAL X-RAY | 1 0.01 1.10 ABNORMAL BEHAVIOUR | 33 0.33 1.43 ABNORMAL DREAMS | 5 0.05 1.48 ABNORMAL FAECES | 1 0.01 1.49 ABNORMAL SENSATION IN EYE | 1 0.01 1.50 ABORTION INDUCED | 5 0.05 1.55 ABORTION MISSED | 1 0.01 1.56 ABORTION SPONTANEOUS | 16 0.16 1.72 ABSCESS | 1 0.01 1.73 ABSCESS DRAINAGE | 1 0.01 1.74 ACCIDENT | 2 0.02 1.76 ACCIDENTAL DRUG INTAKE BY CHILD | 1 0.01 1.77 ACCIDENTAL EXPOSURE | 1 0.01 1.78 ACCIDENTAL NEEDLE STICK | 1 0.01 1.79 ACCIDENTAL OVERDOSE | 4 0.04 1.83 ACCOMMODATION DISORDER | 1 0.01 1.84 ACNE | 2 0.02 1.86 ACROCHORDON | 2 0.02 1.88 ACTINOMYCOSIS | 1 0.01 1.89 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 3 0.03 1.92 ACTIVITIES OF DAILY LIVING IMPAIRED | 3 0.03 1.95 ACUTE ABDOMEN | 1 0.01 1.96 ACUTE CORONARY SYNDROME | 1 0.01 1.97 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 2 0.02 1.99 ACUTE GRAFT VERSUS HOST DISEASE IN IN.. | 1 0.01 2.00 ACUTE HEPATIC FAILURE | 4 0.04 2.04 ACUTE MYELOID LEUKAEMIA | 4 0.04 2.08 ACUTE MYOCARDIAL INFARCTION | 10 0.10 2.18 ACUTE PULMONARY OEDEMA | 1 0.01 2.19 ACUTE RESPIRATORY DISTRESS SYNDROME | 6 0.06 2.25 ACUTE RESPIRATORY FAILURE | 4 0.04 2.29 ADENOCARCINOMA | 1 0.01 2.30 ADENOIDECTOMY | 1 0.01 2.31 ADJUSTMENT DISORDER WITH DEPRESSED MOOD | 1 0.01 2.32 ADRENAL CORTICAL INSUFFICIENCY | 1 0.01 2.33 ADRENAL INSUFFICIENCY | 3 0.03 2.36 ADVERSE DRUG REACTION | 3 0.03 2.39 ADVERSE EVENT | 6 0.06 2.45 AFFECT LABILITY | 5 0.05 2.50 AFFECTIVE DISORDER | 1 0.01 2.51 AGEUSIA | 4 0.04 2.55 AGGRESSION | 15 0.15 2.70 AGITATION | 20 0.20 2.90 AGONAL DEATH STRUGGLE | 1 0.01 2.91 AGRANULOCYTOSIS | 8 0.08 2.99 ALANINE AMINOTRANSFERASE INCREASED | 37 0.37 3.36 ALBUMIN GLOBULIN RATIO DECREASED | 1 0.01 3.37 ALCOHOL POISONING | 1 0.01 3.38 ALCOHOL USE | 1 0.01 3.39 ALCOHOLISM | 2 0.02 3.41 ALICE IN WONDERLAND SYNDROME | 1 0.01 3.42 ALLERGIC GRANULOMATOUS ANGIITIS | 2 0.02 3.44 ALLERGIC SINUSITIS | 1 0.01 3.45 ALLERGIC TRANSFUSION REACTION | 2 0.02 3.47 ALOPECIA | 11 0.11 3.58 ALVEOLITIS | 1 0.01 3.59 ALVEOLITIS ALLERGIC | 1 0.01 3.60 AMENORRHOEA | 3 0.03 3.63 AMNESIA | 44 0.44 4.07 AMPUTATION | 1 0.01 4.08 AMYLOIDOSIS | 1 0.01 4.09 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 4.10 ANAEMIA | 55 0.55 4.65 ANAEMIA VITAMIN B12 DEFICIENCY | 1 0.01 4.66 ANAESTHETIC COMPLICATION | 1 0.01 4.67 ANAL ATRESIA | 1 0.01 4.68 ANAL HAEMORRHAGE | 1 0.01 4.69 ANALGESIC EFFECT | 1 0.01 4.70 ANAPHYLACTIC REACTION | 8 0.08 4.78 ANAPHYLACTIC SHOCK | 12 0.12 4.90 ANAPHYLACTOID REACTION | 5 0.05 4.95 ANASTOMOTIC ULCER | 1 0.01 4.96 ANDROGENS ABNORMAL | 1 0.01 4.97 ANGER | 4 0.04 5.01 ANGINA PECTORIS | 6 0.06 5.07 ANGINA UNSTABLE | 2 0.02 5.09 ANGIOCENTRIC LYMPHOMA | 1 0.01 5.10 ANGIOEDEMA | 8 0.08 5.18 ANGIOPATHY | 5 0.05 5.23 ANGIOPLASTY | 1 0.01 5.24 ANGIOTENSIN CONVERTING ENZYME INCREASED | 1 0.01 5.25 ANHEDONIA | 1 0.01 5.26 ANKLE FRACTURE | 1 0.01 5.27 ANORECTAL DISORDER | 1 0.01 5.28 ANOREXIA | 34 0.34 5.62 ANOSMIA | 2 0.02 5.64 ANOXIC ENCEPHALOPATHY | 1 0.01 5.65 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE | 1 0.01 5.66 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY .. | 1 0.01 5.67 ANTI-PLATELET ANTIBODY POSITIVE | 1 0.01 5.68 ANTICONVULSANT DRUG LEVEL INCREASED | 3 0.03 5.71 ANTIMITOCHONDRIAL ANTIBODY POSITIVE | 1 0.01 5.72 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY P.. | 1 0.01 5.73 ANTINUCLEAR ANTIBODY INCREASED | 2 0.02 5.75 ANTINUCLEAR ANTIBODY POSITIVE | 4 0.04 5.79 ANTIPHOSPHOLIPID ANTIBODIES | 2 0.02 5.81 ANTIPHOSPHOLIPID SYNDROME | 1 0.01 5.82 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAP.. | 1 0.01 5.83 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAP.. | 2 0.02 5.85 ANTIPSYCHOTIC DRUG LEVEL INCREASED | 1 0.01 5.86 ANURIA | 5 0.05 5.91 ANXIETY | 50 0.50 6.41 ANXIETY DISORDER | 1 0.01 6.42 AORTA HYPOPLASIA | 1 0.01 6.43 AORTIC ARTERIOSCLEROSIS | 1 0.01 6.44 AORTIC DILATATION | 1 0.01 6.45 AORTIC STENOSIS | 1 0.01 6.46 AORTIC VALVE INCOMPETENCE | 4 0.04 6.50 AORTIC VALVE SCLEROSIS | 1 0.01 6.51 APATHY | 6 0.06 6.57 APGAR SCORE LOW | 1 0.01 6.58 APHAKIA | 1 0.01 6.59 APHASIA | 4 0.04 6.63 APHONIA | 1 0.01 6.64 APHTHOUS STOMATITIS | 1 0.01 6.65 APICECTOMY | 1 0.01 6.66 APLASIA | 1 0.01 6.67 APLASIA PURE RED CELL | 2 0.02 6.69 APLASTIC ANAEMIA | 1 0.01 6.70 APNOEA | 2 0.02 6.72 APPENDICITIS | 2 0.02 6.74 APPENDICITIS PERFORATED | 1 0.01 6.75 APPLICATION SITE DRYNESS | 1 0.01 6.76 APPLICATION SITE ERYTHEMA | 2 0.02 6.78 APPLICATION SITE IRRITATION | 1 0.01 6.79 APPLICATION SITE NECROSIS | 2 0.02 6.81 APPLICATION SITE PAIN | 1 0.01 6.82 APPLICATION SITE SCAB | 1 0.01 6.83 APPLICATION SITE SCAR | 1 0.01 6.84 APPLICATION SITE VESICLES | 1 0.01 6.85 ARACHNOID CYST | 1 0.01 6.86 ARRHYTHMIA | 16 0.16 7.02 ARTERIAL DISORDER | 1 0.01 7.03 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 7.04 ARTERIAL RUPTURE | 1 0.01 7.05 ARTERIAL STENOSIS | 3 0.03 7.08 ARTERIAL THROMBOSIS LIMB | 1 0.01 7.09 ARTERIOSCLEROSIS | 4 0.04 7.13 ARTERIOSCLEROSIS CORONARY ARTERY | 2 0.02 7.15 ARTERIOSPASM CORONARY | 1 0.01 7.16 ARTERITIS | 2 0.02 7.18 ARTERY DISSECTION | 1 0.01 7.19 ARTHRALGIA | 35 0.35 7.54 ARTHRITIS | 9 0.09 7.63 ARTHRITIS INFECTIVE | 1 0.01 7.64 ARTHROPATHY | 3 0.03 7.67 ARTHROPOD BITE | 1 0.01 7.68 ARTICULAR CALCIFICATION | 1 0.01 7.69 ASCITES | 9 0.09 7.78 ASPARTATE AMINOTRANSFERASE INCREASED | 29 0.29 8.07 ASPERGER'S DISORDER | 1 0.01 8.08 ASPIRATION | 3 0.03 8.11 ASTHENIA | 63 0.63 8.74 ASTHMA | 16 0.16 8.90 ATELECTASIS | 3 0.03 8.93 ATRIAL FIBRILLATION | 24 0.24 9.17 ATRIAL FLUTTER | 3 0.03 9.20 ATRIAL SEPTAL DEFECT | 2 0.02 9.22 ATRIAL THROMBOSIS | 1 0.01 9.23 ATRIOVENTRICULAR BLOCK | 2 0.02 9.25 ATRIOVENTRICULAR BLOCK COMPLETE | 4 0.04 9.29 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 3 0.03 9.32 ATRIOVENTRICULAR EXTRASYSTOLES | 1 0.01 9.33 ATRIOVENTRICULAR SEPTAL DEFECT | 1 0.01 9.34 ATROPHY | 1 0.01 9.35 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 3 0.03 9.38 AUTOIMMUNE DISORDER | 2 0.02 9.40 AUTOIMMUNE HEPATITIS | 1 0.01 9.41 AUTOIMMUNE NEUTROPENIA | 1 0.01 9.42 AUTOIMMUNE THROMBOCYTOPENIA | 1 0.01 9.43 AUTOIMMUNE THYROIDITIS | 2 0.02 9.45 AZOTAEMIA | 1 0.01 9.46 B-CELL LYMPHOMA | 1 0.01 9.47 B-LYMPHOCYTE COUNT INCREASED | 1 0.01 9.48 BACK DISORDER | 2 0.02 9.50 BACK INJURY | 3 0.03 9.53 BACK PAIN | 33 0.33 9.86 BACTERAEMIA | 2 0.02 9.88 BACTERIA STOOL IDENTIFIED | 1 0.01 9.89 BACTERIA URINE | 1 0.01 9.90 BACTERIAL CULTURE POSITIVE | 1 0.01 9.91 BACTERIAL INFECTION | 3 0.03 9.94 BALANCE DISORDER | 17 0.17 10.11 BEDRIDDEN | 1 0.01 10.12 BENIGN INTRACRANIAL HYPERTENSION | 1 0.01 10.13 BENIGN NEOPLASM OF SPINAL CORD | 1 0.01 10.14 BENIGN PROSTATIC HYPERPLASIA | 2 0.02 10.16 BILE DUCT OBSTRUCTION | 1 0.01 10.17 BILIARY CIRRHOSIS PRIMARY | 1 0.01 10.18 BILIARY DILATATION | 1 0.01 10.19 BILIARY TRACT DISORDER | 1 0.01 10.20 BILIARY TRACT INFECTION | 1 0.01 10.21 BILIRUBIN CONJUGATED INCREASED | 2 0.02 10.23 BINGE EATING | 4 0.04 10.27 BIOPSY KIDNEY ABNORMAL | 2 0.02 10.29 BIOPSY LIVER | 1 0.01 10.30 BIOPSY LIVER ABNORMAL | 1 0.01 10.31 BIOPSY SKIN ABNORMAL | 1 0.01 10.32 BIPOLAR DISORDER | 4 0.04 10.36 BLADDER DISORDER | 2 0.02 10.38 BLADDER INJURY | 1 0.01 10.39 BLADDER PAIN | 1 0.01 10.40 BLEPHARITIS | 1 0.01 10.41 BLINDNESS | 10 0.10 10.51 BLINDNESS TRANSIENT | 1 0.01 10.52 BLINDNESS UNILATERAL | 2 0.02 10.54 BLISTER | 7 0.07 10.61 BLOOD ALBUMIN DECREASED | 7 0.07 10.68 BLOOD ALKALINE PHOSPHATASE INCREASED | 19 0.19 10.87 BLOOD AMYLASE INCREASED | 4 0.04 10.91 BLOOD BICARBONATE DECREASED | 1 0.01 10.92 BLOOD BILIRUBIN INCREASED | 15 0.15 11.07 BLOOD BILIRUBIN UNCONJUGATED | 1 0.01 11.08 BLOOD BILIRUBIN UNCONJUGATED INCREASED | 1 0.01 11.09 BLOOD CALCIUM DECREASED | 5 0.05 11.14 BLOOD CALCIUM INCREASED | 1 0.01 11.15 BLOOD CHLORIDE DECREASED | 2 0.02 11.17 BLOOD CHLORIDE INCREASED | 1 0.01 11.18 BLOOD CHOLESTEROL DECREASED | 1 0.01 11.19 BLOOD CHOLESTEROL INCREASED | 11 0.11 11.30 BLOOD CHOLINESTERASE | 1 0.01 11.31 BLOOD CORTICOTROPHIN INCREASED | 1 0.01 11.32 BLOOD CORTISOL DECREASED | 1 0.01 11.33 BLOOD COUNT ABNORMAL | 2 0.02 11.35 BLOOD CREATINE INCREASED | 1 0.01 11.36 BLOOD CREATINE PHOSPHOKINASE | 1 0.01 11.37 BLOOD CREATINE PHOSPHOKINASE INCREASED | 20 0.20 11.57 BLOOD CREATININE DECREASED | 1 0.01 11.58 BLOOD CREATININE INCREASED | 28 0.28 11.86 BLOOD DISORDER | 1 0.01 11.87 BLOOD FIBRINOGEN DECREASED | 1 0.01 11.88 BLOOD FIBRINOGEN INCREASED | 2 0.02 11.90 BLOOD GASES ABNORMAL | 2 0.02 11.92 BLOOD GLUCOSE ABNORMAL | 2 0.02 11.94 BLOOD GLUCOSE DECREASED | 7 0.07 12.01 BLOOD GLUCOSE FLUCTUATION | 1 0.01 12.02 BLOOD GLUCOSE INCREASED | 23 0.23 12.25 BLOOD IMMUNOGLOBULIN A DECREASED | 1 0.01 12.26 BLOOD IMMUNOGLOBULIN G DECREASED | 2 0.02 12.28 BLOOD IMMUNOGLOBULIN G INCREASED | 1 0.01 12.29 BLOOD IMMUNOGLOBULIN M DECREASED | 1 0.01 12.30 BLOOD INSULIN INCREASED | 1 0.01 12.31 BLOOD LACTATE DEHYDROGENASE INCREASED | 7 0.07 12.38 BLOOD LACTIC ACID INCREASED | 1 0.01 12.39 BLOOD MAGNESIUM INCREASED | 1 0.01 12.40 BLOOD OSMOLARITY ABNORMAL | 1 0.01 12.41 BLOOD PARATHYROID HORMONE DECREASED | 1 0.01 12.42 BLOOD PARATHYROID HORMONE INCREASED | 1 0.01 12.43 BLOOD PH DECREASED | 1 0.01 12.44 BLOOD PH INCREASED | 2 0.02 12.46 BLOOD PHOSPHORUS ABNORMAL | 1 0.01 12.47 BLOOD PHOSPHORUS DECREASED | 1 0.01 12.48 BLOOD PHOSPHORUS INCREASED | 1 0.01 12.49 BLOOD POTASSIUM DECREASED | 3 0.03 12.52 BLOOD POTASSIUM INCREASED | 5 0.05 12.57 BLOOD PRESSURE ABNORMAL | 1 0.01 12.58 BLOOD PRESSURE DECREASED | 33 0.33 12.91 BLOOD PRESSURE DIASTOLIC INCREASED | 1 0.01 12.92 BLOOD PRESSURE FLUCTUATION | 1 0.01 12.93 BLOOD PRESSURE INADEQUATELY CONTROLLED | 2 0.02 12.95 BLOOD PRESSURE INCREASED | 21 0.21 13.16 BLOOD PRESSURE ORTHOSTATIC ABNORMAL | 1 0.01 13.17 BLOOD PRESSURE ORTHOSTATIC DECREASED | 1 0.01 13.18 BLOOD PRESSURE SYSTOLIC DECREASED | 2 0.02 13.20 BLOOD PRESSURE SYSTOLIC INCREASED | 1 0.01 13.21 BLOOD SODIUM DECREASED | 5 0.05 13.26 BLOOD SODIUM INCREASED | 1 0.01 13.27 BLOOD STEM CELL HARVEST FAILURE | 1 0.01 13.28 BLOOD TEST ABNORMAL | 1 0.01 13.29 BLOOD THYROID STIMULATING HORMONE DEC.. | 2 0.02 13.31 BLOOD TRIGLYCERIDES INCREASED | 5 0.05 13.36 BLOOD UREA INCREASED | 9 0.09 13.45 BLOOD URIC ACID INCREASED | 3 0.03 13.48 BLOOD URINE PRESENT | 2 0.02 13.50 BLOOD VISCOSITY INCREASED | 1 0.01 13.51 BLOODY DISCHARGE | 1 0.01 13.52 BODY DYSMORPHIC DISORDER | 1 0.01 13.53 BODY TEMPERATURE | 1 0.01 13.54 BODY TEMPERATURE DECREASED | 3 0.03 13.57 BODY TEMPERATURE INCREASED | 2 0.02 13.59 BONE DEBRIDEMENT | 2 0.02 13.61 BONE DENSITY DECREASED | 2 0.02 13.63 BONE DISORDER | 13 0.13 13.76 BONE GRAFT | 1 0.01 13.77 BONE LESION | 1 0.01 13.78 BONE LESION EXCISION | 1 0.01 13.79 BONE MARROW DISORDER | 1 0.01 13.80 BONE MARROW FAILURE | 7 0.07 13.87 BONE MARROW TOXICITY | 1 0.01 13.88 BONE NEOPLASM MALIGNANT | 2 0.02 13.90 BONE PAIN | 10 0.10 14.00 BORRELIA BURGDORFERI SEROLOGY POSITIVE | 1 0.01 14.01 BOVINE TUBERCULOSIS | 1 0.01 14.02 BOWEL SOUNDS ABNORMAL | 2 0.02 14.04 BRADYARRHYTHMIA | 1 0.01 14.05 BRADYCARDIA | 14 0.14 14.19 BRADYPHRENIA | 1 0.01 14.20 BRAIN DAMAGE | 4 0.04 14.24 BRAIN HERNIATION | 2 0.02 14.26 BRAIN NATRIURETIC PEPTIDE DECREASED | 1 0.01 14.27 BRAIN NEOPLASM | 3 0.03 14.30 BRAIN NEOPLASM BENIGN | 1 0.01 14.31 BRAIN NEOPLASM MALIGNANT | 1 0.01 14.32 BRAIN OEDEMA | 6 0.06 14.38 BRAIN OPERATION | 2 0.02 14.40 BREAKTHROUGH PAIN | 1 0.01 14.41 BREAST CANCER | 11 0.11 14.52 BREAST CANCER FEMALE | 5 0.05 14.57 BREAST CANCER IN SITU | 1 0.01 14.58 BREAST CANCER METASTATIC | 2 0.02 14.60 BREAST CELLULITIS | 1 0.01 14.61 BREAST CYST | 1 0.01 14.62 BREAST MASS | 3 0.03 14.65 BREAST NEOPLASM | 1 0.01 14.66 BREAST SWELLING | 1 0.01 14.67 BREAST TENDERNESS | 1 0.01 14.68 BREATH ODOUR | 1 0.01 14.69 BREATH SOUNDS ABNORMAL | 1 0.01 14.70 BRONCHIAL HYPERREACTIVITY | 1 0.01 14.71 BRONCHIAL OBSTRUCTION | 2 0.02 14.73 BRONCHITIS | 8 0.08 14.81 BRONCHOALVEOLAR LAVAGE | 1 0.01 14.82 BRONCHOPNEUMONIA | 4 0.04 14.86 BRONCHOPULMONARY ASPERGILLOSIS | 2 0.02 14.88 BRONCHOPULMONARY DYSPLASIA | 1 0.01 14.89 BRONCHOSCOPY | 1 0.01 14.90 BRONCHOSPASM | 8 0.08 14.98 BRUXISM | 1 0.01 14.99 BUNDLE BRANCH BLOCK LEFT | 4 0.04 15.03 BUNDLE BRANCH BLOCK RIGHT | 2 0.02 15.05 BURNING SENSATION | 10 0.10 15.15 BURSITIS | 2 0.02 15.17 C-REACTIVE PROTEIN INCREASED | 20 0.20 15.37 CACHEXIA | 3 0.03 15.40 CAESAREAN SECTION | 3 0.03 15.43 CALCINOSIS | 2 0.02 15.45 CALCIPHYLAXIS | 2 0.02 15.47 CALCULUS BLADDER | 1 0.01 15.48 CALCULUS URETERIC | 1 0.01 15.49 CANDIDIASIS | 3 0.03 15.52 CAPILLARY LEAK SYNDROME | 1 0.01 15.53 CARBON DIOXIDE DECREASED | 1 0.01 15.54 CARDIAC ARREST | 22 0.22 15.76 CARDIAC DISORDER | 13 0.13 15.89 CARDIAC ENZYMES INCREASED | 2 0.02 15.91 CARDIAC FAILURE | 20 0.20 16.11 CARDIAC FAILURE ACUTE | 3 0.03 16.14 CARDIAC FAILURE CHRONIC | 1 0.01 16.15 CARDIAC FAILURE CONGESTIVE | 15 0.15 16.30 CARDIAC FLUTTER | 1 0.01 16.31 CARDIAC MASSAGE | 1 0.01 16.32 CARDIAC MURMUR | 6 0.06 16.38 CARDIAC OPERATION | 1 0.01 16.39 CARDIAC OUTPUT DECREASED | 1 0.01 16.40 CARDIAC STRESS TEST ABNORMAL | 2 0.02 16.42 CARDIAC VALVE DISEASE | 3 0.03 16.45 CARDIO-RESPIRATORY ARREST | 22 0.22 16.67 CARDIOACTIVE DRUG LEVEL ABOVE THERAPE.. | 1 0.01 16.68 CARDIOACTIVE DRUG LEVEL DECREASED | 1 0.01 16.69 CARDIOGENIC SHOCK | 5 0.05 16.74 CARDIOMEGALY | 9 0.09 16.83 CARDIOMYOPATHY | 2 0.02 16.85 CARDIOPULMONARY FAILURE | 1 0.01 16.86 CARDIOTOXICITY | 4 0.04 16.90 CARDIOVASCULAR DISORDER | 25 0.25 17.15 CAROTID ARTERY OCCLUSION | 1 0.01 17.16 CAROTID ARTERY STENOSIS | 1 0.01 17.17 CAROTID ARTERY THROMBOSIS | 3 0.03 17.20 CAROTID PULSE DECREASED | 1 0.01 17.21 CARPAL TUNNEL SYNDROME | 3 0.03 17.24 CARTILAGE INJURY | 2 0.02 17.26 CATARACT | 8 0.08 17.34 CATATONIA | 3 0.03 17.37 CATECHOLAMINES URINE INCREASED | 1 0.01 17.38 CATHETER RELATED COMPLICATION | 9 0.09 17.47 CATHETER RELATED INFECTION | 3 0.03 17.50 CATHETER SITE ERYTHEMA | 1 0.01 17.51 CATHETER SITE HAEMORRHAGE | 1 0.01 17.52 CATHETER SITE OEDEMA | 1 0.01 17.53 CATHETER SITE PAIN | 2 0.02 17.55 CATHETERISATION CARDIAC | 1 0.01 17.56 CAUSTIC INJURY | 1 0.01 17.57 CD4 LYMPHOCYTES DECREASED | 2 0.02 17.59 CELL DEATH | 2 0.02 17.61 CELLULITIS | 9 0.09 17.70 CELLULITIS STAPHYLOCOCCAL | 1 0.01 17.71 CENTRAL LINE INFECTION | 1 0.01 17.72 CENTRAL NERVOUS SYSTEM INFECTION | 1 0.01 17.73 CENTRAL VENOUS CATHETERISATION | 1 0.01 17.74 CEREBELLAR INFARCTION | 1 0.01 17.75 CEREBRAL ARTERY EMBOLISM | 2 0.02 17.77 CEREBRAL ARTERY THROMBOSIS | 1 0.01 17.78 CEREBRAL ATROPHY | 2 0.02 17.80 CEREBRAL DISORDER | 2 0.02 17.82 CEREBRAL HAEMORRHAGE | 8 0.08 17.90 CEREBRAL INFARCTION | 12 0.12 18.02 CEREBRAL ISCHAEMIA | 4 0.04 18.06 CEREBRAL PALSY | 1 0.01 18.07 CEREBRAL VENOUS THROMBOSIS | 1 0.01 18.08 CEREBROVASCULAR ACCIDENT | 35 0.35 18.43 CEREBROVASCULAR DISORDER | 5 0.05 18.48 CERUMEN IMPACTION | 1 0.01 18.49 CERVICAL SPINAL STENOSIS | 1 0.01 18.50 CERVICAL VERTEBRAL FRACTURE | 1 0.01 18.51 CERVICITIS | 1 0.01 18.52 CERVIX CARCINOMA | 2 0.02 18.54 CERVIX DYSTOCIA | 1 0.01 18.55 CHANGE OF BOWEL HABIT | 1 0.01 18.56 CHAPPED LIPS | 1 0.01 18.57 CHEILITIS | 2 0.02 18.59 CHEMICAL POISONING | 1 0.01 18.60 CHEMOTHERAPY | 1 0.01 18.61 CHEST DISCOMFORT | 23 0.23 18.84 CHEST INJURY | 1 0.01 18.85 CHEST PAIN | 53 0.53 19.38 CHEST X-RAY ABNORMAL | 4 0.04 19.42 CHILD ABUSE | 1 0.01 19.43 CHILLS | 30 0.30 19.73 CHLOASMA | 1 0.01 19.74 CHOKING | 4 0.04 19.78 CHOKING SENSATION | 1 0.01 19.79 CHOLANGITIS SCLEROSING | 1 0.01 19.80 CHOLECYSTECTOMY | 4 0.04 19.84 CHOLECYSTITIS | 3 0.03 19.87 CHOLECYSTITIS ACUTE | 2 0.02 19.89 CHOLELITHIASIS | 10 0.10 19.99 CHOLESTASIS | 9 0.09 20.08 CHONDRITIS | 1 0.01 20.09 CHONDROPATHY | 1 0.01 20.10 CHORIOMENINGITIS LYMPHOCYTIC | 1 0.01 20.11 CHOROIDAL DETACHMENT | 1 0.01 20.12 CHROMATURIA | 3 0.03 20.15 CHROMOSOME ABNORMALITY | 1 0.01 20.16 CHRONIC GASTROINTESTINAL BLEEDING | 1 0.01 20.17 CHRONIC GRAFT VERSUS HOST DISEASE | 3 0.03 20.20 CHRONIC HEPATIC FAILURE | 2 0.02 20.22 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 6 0.06 20.28 CIRCULATORY COLLAPSE | 8 0.08 20.36 CIRCUMSTANCE OR INFORMATION CAPABLE O.. | 1 0.01 20.37 CLAVICLE FRACTURE | 2 0.02 20.39 CLEFT LIP | 1 0.01 20.40 CLEFT LIP AND PALATE | 1 0.01 20.41 CLEFT PALATE | 1 0.01 20.42 CLONIC CONVULSION | 1 0.01 20.43 CLOSTRIDIAL INFECTION | 2 0.02 20.45 CLOSTRIDIUM DIFFICILE COLITIS | 3 0.03 20.48 CLOSTRIDIUM DIFFICILE TOXIN TEST POSI.. | 2 0.02 20.50 COAGULATION FACTOR | 1 0.01 20.51 COAGULATION TEST ABNORMAL | 1 0.01 20.52 COAGULOPATHY | 4 0.04 20.56 COARCTATION OF THE AORTA | 1 0.01 20.57 COGNITIVE DISORDER | 13 0.13 20.70 COLD SWEAT | 4 0.04 20.74 COLECTOMY TOTAL | 1 0.01 20.75 COLITIS | 10 0.10 20.85 COLITIS COLLAGENOUS | 1 0.01 20.86 COLITIS ULCERATIVE | 12 0.12 20.98 COLLAGEN DISORDER | 1 0.01 20.99 COLLAPSE OF LUNG | 1 0.01 21.00 COLON CANCER | 1 0.01 21.01 COLON OPERATION | 1 0.01 21.02 COLONIC HAEMATOMA | 1 0.01 21.03 COLONIC POLYP | 1 0.01 21.04 COLONIC STENOSIS | 1 0.01 21.05 COLONOSCOPY | 2 0.02 21.07 COLOUR VISION TESTS ABNORMAL | 1 0.01 21.08 COMA | 7 0.07 21.15 COMA HEPATIC | 1 0.01 21.16 COMMUNICATION DISORDER | 2 0.02 21.18 COMPLETED SUICIDE | 11 0.11 21.29 COMPLEX REGIONAL PAIN SYNDROME | 1 0.01 21.30 COMPLICATIONS OF BONE MARROW TRANSPLANT | 1 0.01 21.31 COMPLICATIONS OF TRANSPLANT SURGERY | 3 0.03 21.34 COMPLICATIONS OF TRANSPLANTED KIDNEY | 1 0.01 21.35 COMPRESSION FRACTURE | 2 0.02 21.37 COMPULSIONS | 1 0.01 21.38 COMPUTERISED TOMOGRAM ABNORMAL | 3 0.03 21.41 CONCOMITANT DISEASE PROGRESSION | 1 0.01 21.42 CONCUSSION | 2 0.02 21.44 CONDITION AGGRAVATED | 35 0.35 21.79 CONFUSIONAL STATE | 44 0.44 22.23 CONGENITAL BOWING OF LONG BONES | 1 0.01 22.24 CONGENITAL ENDOCRINE ANOMALY | 1 0.01 22.25 CONGENITAL FOOT MALFORMATION | 1 0.01 22.26 CONGENITAL HEART VALVE DISORDER | 1 0.01 22.27 CONGENITAL HYDRONEPHROSIS | 1 0.01 22.28 CONGENITAL MUSCULOSKELETAL ANOMALY | 1 0.01 22.29 CONGESTIVE CARDIOMYOPATHY | 3 0.03 22.32 CONJUNCTIVAL HYPERAEMIA | 1 0.01 22.33 CONJUNCTIVITIS | 8 0.08 22.41 CONSTIPATION | 34 0.34 22.75 CONTACT LENS COMPLICATION | 1 0.01 22.76 CONTRAST MEDIA REACTION | 1 0.01 22.77 CONTUSION | 16 0.16 22.93 CONVERSION DISORDER | 1 0.01 22.94 CONVULSION | 51 0.51 23.45 CONVULSIVE THRESHOLD LOWERED | 1 0.01 23.46 COOMBS TEST POSITIVE | 1 0.01 23.47 COORDINATION ABNORMAL | 9 0.09 23.56 COPPER DEFICIENCY | 1 0.01 23.57 CORNEAL DISORDER | 1 0.01 23.58 CORNEAL EPITHELIUM DEFECT | 1 0.01 23.59 CORONARY ANGIOPLASTY | 1 0.01 23.60 CORONARY ARTERY BYPASS | 2 0.02 23.62 CORONARY ARTERY DISEASE | 6 0.06 23.68 CORONARY ARTERY OCCLUSION | 3 0.03 23.71 CORTISOL FREE URINE DECREASED | 1 0.01 23.72 COUGH | 29 0.29 24.01 CRANIAL NERVE DISORDER | 1 0.01 24.02 CRANIAL NERVE PARALYSIS | 1 0.01 24.03 CREATININE RENAL CLEARANCE DECREASED | 2 0.02 24.05 CREPITATIONS | 1 0.01 24.06 CREST SYNDROME | 1 0.01 24.07 CROHN'S DISEASE | 8 0.08 24.15 CRYING | 11 0.11 24.26 CRYPTOGENIC ORGANISING PNEUMONIA | 2 0.02 24.28 CULTURE THROAT POSITIVE | 1 0.01 24.29 CULTURE URINE POSITIVE | 2 0.02 24.31 CUTANEOUS VASCULITIS | 1 0.01 24.32 CYANOSIS | 9 0.09 24.41 CYST | 3 0.03 24.44 CYST ASPIRATION | 1 0.01 24.45 CYSTITIS | 6 0.06 24.51 CYSTITIS HAEMORRHAGIC | 2 0.02 24.53 CYSTITIS INTERSTITIAL | 1 0.01 24.54 CYSTOPEXY | 1 0.01 24.55 CYTOLYTIC HEPATITIS | 8 0.08 24.63 CYTOMEGALOVIRUS INFECTION | 5 0.05 24.68 CYTOMEGALOVIRUS TEST | 1 0.01 24.69 CYTOMEGALOVIRUS VIRAEMIA | 2 0.02 24.71 CYTOTOXIC CARDIOMYOPATHY | 1 0.01 24.72 DEAFNESS | 9 0.09 24.81 DEAFNESS NEUROSENSORY | 1 0.01 24.82 DEAFNESS UNILATERAL | 1 0.01 24.83 DEATH | 124 1.24 26.07 DECREASED ACTIVITY | 1 0.01 26.08 DECREASED APPETITE | 14 0.14 26.22 DECREASED IMMUNE RESPONSIVENESS | 1 0.01 26.23 DECREASED INTEREST | 3 0.03 26.26 DECUBITUS ULCER | 2 0.02 26.28 DEEP VEIN THROMBOSIS | 14 0.14 26.42 DEHYDRATION | 43 0.43 26.85 DELIRIUM | 13 0.13 26.98 DELUSION | 7 0.07 27.05 DEMENTIA | 4 0.04 27.09 DEMENTIA ALZHEIMER'S TYPE | 2 0.02 27.11 DEMYELINATION | 2 0.02 27.13 DENTAL CARIES | 2 0.02 27.15 DENTAL CLEANING | 1 0.01 27.16 DENTAL EXAMINATION ABNORMAL | 2 0.02 27.18 DENTAL OPERATION | 2 0.02 27.20 DENTAL TREATMENT | 3 0.03 27.23 DENTURE WEARER | 1 0.01 27.24 DEPENDENCE | 8 0.08 27.32 DEPERSONALISATION | 2 0.02 27.34 DEPRESSED LEVEL OF CONSCIOUSNESS | 31 0.31 27.65 DEPRESSED MOOD | 5 0.05 27.70 DEPRESSION | 68 0.68 28.38 DEPRESSION SUICIDAL | 1 0.01 28.39 DEREALISATION | 1 0.01 28.40 DERMATITIS | 5 0.05 28.45 DERMATITIS ACNEIFORM | 1 0.01 28.46 DERMATITIS ATOPIC | 1 0.01 28.47 DERMATITIS BULLOUS | 1 0.01 28.48 DERMATITIS CONTACT | 2 0.02 28.50 DERMATITIS DIAPER | 1 0.01 28.51 DERMATITIS EXFOLIATIVE | 1 0.01 28.52 DERMATITIS EXFOLIATIVE GENERALISED | 1 0.01 28.53 DERMATOMYOSITIS | 3 0.03 28.56 DEVELOPMENTAL DELAY | 1 0.01 28.57 DEVICE FAILURE | 1 0.01 28.58 DEVICE LEAKAGE | 2 0.02 28.60 DEVICE MALFUNCTION | 2 0.02 28.62 DIABETES INSIPIDUS | 2 0.02 28.64 DIABETES MELLITUS | 94 0.94 29.58 DIABETES MELLITUS INADEQUATE CONTROL | 4 0.04 29.62 DIABETES MELLITUS INSULIN-DEPENDENT | 9 0.09 29.71 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 29 0.29 30.00 DIABETIC COMA | 11 0.11 30.11 DIABETIC COMPLICATION | 1 0.01 30.12 DIABETIC HYPEROSMOLAR COMA | 1 0.01 30.13 DIABETIC KETOACIDOSIS | 7 0.07 30.20 DIABETIC NEPHROPATHY | 1 0.01 30.21 DIABETIC NEUROPATHY | 1 0.01 30.22 DIABETIC RETINOPATHY | 1 0.01 30.23 DIALYSIS | 2 0.02 30.25 DIARRHOEA | 88 0.88 31.13 DIARRHOEA HAEMORRHAGIC | 4 0.04 31.17 DIASTOLIC DYSFUNCTION | 2 0.02 31.19 DIFFUSE LARGE B-CELL LYMPHOMA | 1 0.01 31.20 DIFFUSE PANBRONCHIOLITIS | 1 0.01 31.21 DILATATION ATRIAL | 2 0.02 31.23 DIPLOPIA | 2 0.02 31.25 DISABLED RELATIVE | 1 0.01 31.26 DISCOMFORT | 6 0.06 31.32 DISEASE PROGRESSION | 12 0.12 31.44 DISEASE RECURRENCE | 2 0.02 31.46 DISORDER OF ORBIT | 1 0.01 31.47 DISORIENTATION | 11 0.11 31.58 DISSEMINATED INTRAVASCULAR COAGULATION | 6 0.06 31.64 DISSEMINATED TUBERCULOSIS | 2 0.02 31.66 DISSOCIATION | 2 0.02 31.68 DISTRACTIBILITY | 1 0.01 31.69 DISTURBANCE IN ATTENTION | 10 0.10 31.79 DIVERTICULITIS | 3 0.03 31.82 DIVERTICULUM | 3 0.03 31.85 DIZZINESS | 68 0.68 32.53 DIZZINESS POSTURAL | 1 0.01 32.54 DROOLING | 1 0.01 32.55 DRUG ABUSER | 6 0.06 32.61 DRUG ADMINISTRATION ERROR | 2 0.02 32.63 DRUG DEPENDENCE | 7 0.07 32.70 DRUG DISPENSING ERROR | 4 0.04 32.74 DRUG DOSE OMISSION | 1 0.01 32.75 DRUG EFFECT DECREASED | 3 0.03 32.78 DRUG EFFECT INCREASED | 1 0.01 32.79 DRUG ERUPTION | 9 0.09 32.88 DRUG EXPOSURE DURING PREGNANCY | 44 0.44 33.32 DRUG EXPOSURE VIA BREAST MILK | 3 0.03 33.35 DRUG HYPERSENSITIVITY | 12 0.12 33.47 DRUG INEFFECTIVE | 48 0.48 33.95 DRUG INTERACTION | 54 0.54 34.49 DRUG INTERACTION POTENTIATION | 2 0.02 34.51 DRUG INTOLERANCE | 1 0.01 34.52 DRUG LEVEL DECREASED | 2 0.02 34.54 DRUG LEVEL INCREASED | 3 0.03 34.57 DRUG PRESCRIBING ERROR | 1 0.01 34.58 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 7 0.07 34.65 DRUG SCREEN FALSE POSITIVE | 1 0.01 34.66 DRUG SCREEN POSITIVE | 2 0.02 34.68 DRUG TOLERANCE | 2 0.02 34.70 DRUG TOXICITY | 17 0.17 34.87 DRUG WITHDRAWAL SYNDROME | 20 0.20 35.07 DRY EYE | 4 0.04 35.11 DRY GANGRENE | 2 0.02 35.13 DRY MOUTH | 7 0.07 35.20 DRY SKIN | 5 0.05 35.25 DRY THROAT | 1 0.01 35.26 DUODENAL PERFORATION | 1 0.01 35.27 DUODENAL STENOSIS | 1 0.01 35.28 DUODENAL ULCER | 5 0.05 35.33 DUODENAL ULCER HAEMORRHAGE | 1 0.01 35.34 DUODENAL ULCER PERFORATION | 3 0.03 35.37 DUODENITIS | 2 0.02 35.39 DYSACUSIS | 1 0.01 35.40 DYSAESTHESIA | 1 0.01 35.41 DYSARTHRIA | 10 0.10 35.51 DYSGEUSIA | 6 0.06 35.57 DYSGLOBULINAEMIA | 1 0.01 35.58 DYSKINESIA | 11 0.11 35.69 DYSLALIA | 1 0.01 35.70 DYSMENORRHOEA | 3 0.03 35.73 DYSMORPHISM | 1 0.01 35.74 DYSPAREUNIA | 2 0.02 35.76 DYSPEPSIA | 8 0.08 35.84 DYSPHAGIA | 14 0.14 35.98 DYSPHASIA | 2 0.02 36.00 DYSPHONIA | 4 0.04 36.04 DYSPHORIA | 1 0.01 36.05 DYSPNOEA | 100 1.00 37.05 DYSPNOEA EXERTIONAL | 7 0.07 37.12 DYSPNOEA PAROXYSMAL NOCTURNAL | 1 0.01 37.13 DYSSOMNIA | 1 0.01 37.14 DYSSTASIA | 6 0.06 37.20 DYSTHYMIC DISORDER | 1 0.01 37.21 DYSTONIA | 3 0.03 37.24 DYSURIA | 12 0.12 37.36 EAR DISCOMFORT | 2 0.02 37.38 EAR DISORDER | 2 0.02 37.40 EAR INFECTION | 1 0.01 37.41 EAR PAIN | 5 0.05 37.46 EAR TUBE INSERTION | 1 0.01 37.47 EATING DISORDER | 12 0.12 37.59 ECCHYMOSIS | 2 0.02 37.61 ECTOPIC PREGNANCY | 1 0.01 37.62 ECZEMA | 4 0.04 37.66 EHLERS-DANLOS SYNDROME | 1 0.01 37.67 EJACULATION DISORDER | 1 0.01 37.68 EJECTION FRACTION DECREASED | 3 0.03 37.71 ELECTROCARDIOGRAM | 1 0.01 37.72 ELECTROCARDIOGRAM CHANGE | 1 0.01 37.73 ELECTROCARDIOGRAM P WAVE ABNORMAL | 1 0.01 37.74 ELECTROCARDIOGRAM PQ INTERVAL PROLONGED | 1 0.01 37.75 ELECTROCARDIOGRAM PR PROLONGATION | 1 0.01 37.76 ELECTROCARDIOGRAM QT CORRECTED INTERV.. | 3 0.03 37.79 ELECTROCARDIOGRAM QT PROLONGED | 11 0.11 37.90 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 2 0.02 37.92 ELEVATED MOOD | 1 0.01 37.93 EMBOLIA CUTIS MEDICAMENTOSA | 1 0.01 37.94 EMBOLISM | 1 0.01 37.95 EMOTIONAL DISORDER | 3 0.03 37.98 EMOTIONAL DISTRESS | 4 0.04 38.02 EMPHYSEMA | 3 0.03 38.05 ENANTHEMA | 1 0.01 38.06 ENCEPHALITIS | 2 0.02 38.08 ENCEPHALOPATHY | 7 0.07 38.15 ENDARTERECTOMY | 1 0.01 38.16 ENDODONTIC PROCEDURE | 3 0.03 38.19 ENDOMETRIAL ATROPHY | 1 0.01 38.20 ENDOMETRIAL CANCER STAGE I | 1 0.01 38.21 ENDOMETRITIS | 1 0.01 38.22 ENDOTRACHEAL INTUBATION COMPLICATION | 1 0.01 38.23 ENGRAFTMENT SYNDROME | 1 0.01 38.24 ENTERITIS | 1 0.01 38.25 ENTEROBACTER INFECTION | 1 0.01 38.26 ENTEROCOCCAL INFECTION | 1 0.01 38.27 ENTEROCOLITIS HAEMORRHAGIC | 4 0.04 38.31 ENTEROCOLITIS INFECTIOUS | 1 0.01 38.32 EOSINOPHIL COUNT INCREASED | 2 0.02 38.34 EOSINOPHILIA | 6 0.06 38.40 EOSINOPHILIC MYOCARDITIS | 1 0.01 38.41 EOSINOPHILIC PNEUMONIA | 2 0.02 38.43 EPILEPSY | 9 0.09 38.52 EPISTAXIS | 8 0.08 38.60 EPSTEIN-BARR VIRUS INFECTION | 2 0.02 38.62 EPSTEIN-BARR VIRUS TEST POSITIVE | 1 0.01 38.63 ERECTILE DYSFUNCTION | 6 0.06 38.69 ERUCTATION | 2 0.02 38.71 ERYTHEMA | 26 0.26 38.97 ERYTHEMA MULTIFORME | 3 0.03 39.00 ERYTHEMA NODOSUM | 1 0.01 39.01 ESCHAR | 3 0.03 39.04 ESCHERICHIA INFECTION | 1 0.01 39.05 ESCHERICHIA URINARY TRACT INFECTION | 3 0.03 39.08 ESSENTIAL HYPERTENSION | 2 0.02 39.10 ESSENTIAL THROMBOCYTHAEMIA | 1 0.01 39.11 EUPHORIC MOOD | 3 0.03 39.14 EUSTACHIAN TUBE DYSFUNCTION | 2 0.02 39.16 EXCESSIVE GRANULATION TISSUE | 1 0.01 39.17 EXCORIATION | 4 0.04 39.21 EXERCISE TEST ABNORMAL | 1 0.01 39.22 EXERCISE TOLERANCE DECREASED | 2 0.02 39.24 EXFOLIATIVE RASH | 1 0.01 39.25 EXOMPHALOS | 1 0.01 39.26 EXOPHTHALMOS | 1 0.01 39.27 EXOSTOSIS | 1 0.01 39.28 EXTENSOR PLANTAR RESPONSE | 1 0.01 39.29 EXTERNAL EAR DISORDER | 1 0.01 39.30 EXTRAPYRAMIDAL DISORDER | 4 0.04 39.34 EXTRASYSTOLES | 2 0.02 39.36 EXTREMITY NECROSIS | 1 0.01 39.37 EYE DISORDER | 9 0.09 39.46 EYE HAEMORRHAGE | 4 0.04 39.50 EYE INJURY | 1 0.01 39.51 EYE IRRITATION | 2 0.02 39.53 EYE LUXATION | 1 0.01 39.54 EYE MOVEMENT DISORDER | 3 0.03 39.57 EYE OEDEMA | 1 0.01 39.58 EYE PAIN | 5 0.05 39.63 EYE PRURITUS | 2 0.02 39.65 EYE ROLLING | 2 0.02 39.67 EYE SWELLING | 8 0.08 39.75 EYEBALL AVULSION | 1 0.01 39.76 EYELID DISORDER | 1 0.01 39.77 EYELID OEDEMA | 3 0.03 39.80 FACE OEDEMA | 14 0.14 39.94 FACET JOINT SYNDROME | 2 0.02 39.96 FACIAL BONES FRACTURE | 2 0.02 39.98 FACIAL PALSY | 2 0.02 40.00 FAECAL INCONTINENCE | 1 0.01 40.01 FAECAL VOMITING | 1 0.01 40.02 FAECALOMA | 2 0.02 40.04 FAECES DISCOLOURED | 4 0.04 40.08 FAILURE TO THRIVE | 2 0.02 40.10 FALL | 66 0.66 40.76 FALLOPIAN TUBE OPERATION | 1 0.01 40.77 FALLOT'S TETRALOGY | 1 0.01 40.78 FAMILY STRESS | 1 0.01 40.79 FATIGUE | 70 0.70 41.49 FEAR | 7 0.07 41.56 FEAR OF DEATH | 1 0.01 41.57 FEBRILE CONVULSION | 1 0.01 41.58 FEBRILE NEUTROPENIA | 19 0.19 41.77 FEEDING DISORDER NEONATAL | 1 0.01 41.78 FEELING ABNORMAL | 23 0.23 42.01 FEELING COLD | 4 0.04 42.05 FEELING DRUNK | 4 0.04 42.09 FEELING HOT | 7 0.07 42.16 FEELING HOT AND COLD | 1 0.01 42.17 FEELING OF DESPAIR | 1 0.01 42.18 FEELING OF RELAXATION | 1 0.01 42.19 FEMORAL ARTERY OCCLUSION | 2 0.02 42.21 FEMORAL NECK FRACTURE | 3 0.03 42.24 FEMUR FRACTURE | 4 0.04 42.28 FIBRIN D DIMER DECREASED | 1 0.01 42.29 FIBRIN D DIMER INCREASED | 1 0.01 42.30 FIBRIN DEGRADATION PRODUCTS INCREASED | 2 0.02 42.32 FIBROADENOMA OF BREAST | 1 0.01 42.33 FIBROMYALGIA | 1 0.01 42.34 FIBULA FRACTURE | 1 0.01 42.35 FINGER AMPUTATION | 1 0.01 42.36 FISTULA | 5 0.05 42.41 FIXED ERUPTION | 1 0.01 42.42 FLANK PAIN | 2 0.02 42.44 FLATULENCE | 8 0.08 42.52 FLUID OVERLOAD | 2 0.02 42.54 FLUID RETENTION | 3 0.03 42.57 FLUSHING | 14 0.14 42.71 FOAMING AT MOUTH | 1 0.01 42.72 FOCAL GLOMERULOSCLEROSIS | 2 0.02 42.74 FOETAL GROWTH RETARDATION | 2 0.02 42.76 FOETAL HEART RATE DECELERATION | 1 0.01 42.77 FOOD CRAVING | 1 0.01 42.78 FOOT FRACTURE | 1 0.01 42.79 FOREARM FRACTURE | 1 0.01 42.80 FOREIGN BODY TRAUMA | 1 0.01 42.81 FORMICATION | 3 0.03 42.84 FRACTURE | 4 0.04 42.88 FRACTURE DELAYED UNION | 1 0.01 42.89 FRACTURED SACRUM | 1 0.01 42.90 FULL BLOOD COUNT ABNORMAL | 1 0.01 42.91 FULL BLOOD COUNT DECREASED | 1 0.01 42.92 FUNGAL INFECTION | 3 0.03 42.95 GAIT DISTURBANCE | 29 0.29 43.24 GALACTORRHOEA | 1 0.01 43.25 GALLBLADDER DISORDER | 5 0.05 43.30 GALLBLADDER OPERATION | 1 0.01 43.31 GALLBLADDER PAIN | 2 0.02 43.33 GAMBLING | 1 0.01 43.34 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL | 1 0.01 43.35 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 20 0.20 43.55 GANGRENE | 2 0.02 43.57 GASTRIC DISORDER | 3 0.03 43.60 GASTRIC HAEMORRHAGE | 4 0.04 43.64 GASTRIC HYPERTONIA | 1 0.01 43.65 GASTRIC POLYPS | 2 0.02 43.67 GASTRIC ULCER | 10 0.10 43.77 GASTRIC ULCER HAEMORRHAGE | 3 0.03 43.80 GASTRITIS | 5 0.05 43.85 GASTRITIS HAEMORRHAGIC | 1 0.01 43.86 GASTROENTERITIS | 4 0.04 43.90 GASTROENTERITIS EOSINOPHILIC | 1 0.01 43.91 GASTROENTERITIS ROTAVIRUS | 1 0.01 43.92 GASTROENTERITIS VIRAL | 3 0.03 43.95 GASTROINTESTINAL DISORDER | 9 0.09 44.04 GASTROINTESTINAL HAEMORRHAGE | 16 0.16 44.20 GASTROINTESTINAL INFECTION | 2 0.02 44.22 GASTROINTESTINAL ISCHAEMIA | 1 0.01 44.23 GASTROINTESTINAL NECROSIS | 2 0.02 44.25 GASTROINTESTINAL NEOPLASM | 1 0.01 44.26 GASTROINTESTINAL PERFORATION | 1 0.01 44.27 GASTROINTESTINAL STOMA COMPLICATION | 1 0.01 44.28 GASTROINTESTINAL TRACT ADENOMA | 1 0.01 44.29 GASTROINTESTINAL ULCER | 1 0.01 44.30 GASTROOESOPHAGEAL REFLUX DISEASE | 9 0.09 44.39 GAZE PALSY | 3 0.03 44.42 GENE MUTATION IDENTIFICATION TEST POS.. | 1 0.01 44.43 GENERAL PHYSICAL HEALTH DETERIORATION | 16 0.16 44.59 GENERALISED ERYTHEMA | 1 0.01 44.60 GENERALISED OEDEMA | 4 0.04 44.64 GENITAL DISORDER MALE | 1 0.01 44.65 GENITAL INFECTION FEMALE | 1 0.01 44.66 GENITAL LESION | 1 0.01 44.67 GENITAL RASH | 1 0.01 44.68 GINGIVAL ABSCESS | 1 0.01 44.69 GINGIVAL BLEEDING | 3 0.03 44.72 GINGIVAL DISORDER | 1 0.01 44.73 GINGIVAL EROSION | 1 0.01 44.74 GINGIVAL HYPERTROPHY | 1 0.01 44.75 GINGIVAL INFECTION | 1 0.01 44.76 GINGIVAL PAIN | 2 0.02 44.78 GINGIVAL RECESSION | 1 0.01 44.79 GINGIVAL SWELLING | 2 0.02 44.81 GINGIVITIS | 2 0.02 44.83 GLAUCOMA | 8 0.08 44.91 GLOBULINS DECREASED | 1 0.01 44.92 GLOMERULAR FILTRATION RATE DECREASED | 2 0.02 44.94 GLOMERULONEPHRITIS | 3 0.03 44.97 GLOMERULONEPHRITIS MEMBRANOUS | 1 0.01 44.98 GLOSSODYNIA | 3 0.03 45.01 GLUCOSE TOLERANCE IMPAIRED | 3 0.03 45.04 GLYCOSYLATED HAEMOGLOBIN INCREASED | 3 0.03 45.07 GOITRE | 1 0.01 45.08 GOUT | 2 0.02 45.10 GRAFT DYSFUNCTION | 1 0.01 45.11 GRAFT ISCHAEMIA | 1 0.01 45.12 GRAFT VERSUS HOST DISEASE | 3 0.03 45.15 GRAND MAL CONVULSION | 8 0.08 45.23 GRANULOCYTOPENIA | 2 0.02 45.25 GROIN PAIN | 2 0.02 45.27 GROWTH RETARDATION | 5 0.05 45.32 GUILLAIN-BARRE SYNDROME | 1 0.01 45.33 GYNAECOMASTIA | 2 0.02 45.35 HAEMANGIOMA OF SKIN | 1 0.01 45.36 HAEMATEMESIS | 13 0.13 45.49 HAEMATOCHEZIA | 8 0.08 45.57 HAEMATOCRIT DECREASED | 6 0.06 45.63 HAEMATOCRIT INCREASED | 1 0.01 45.64 HAEMATOMA | 5 0.05 45.69 HAEMATOMA INFECTION | 1 0.01 45.70 HAEMATOTOXICITY | 1 0.01 45.71 HAEMATURIA | 6 0.06 45.77 HAEMODIALYSIS | 4 0.04 45.81 HAEMODIALYSIS-INDUCED SYMPTOM | 1 0.01 45.82 HAEMODYNAMIC INSTABILITY | 1 0.01 45.83 HAEMOGLOBIN DECREASED | 12 0.12 45.95 HAEMOGLOBIN INCREASED | 2 0.02 45.97 HAEMOLYSIS | 3 0.03 46.00 HAEMOLYTIC ANAEMIA | 4 0.04 46.04 HAEMOLYTIC URAEMIC SYNDROME | 2 0.02 46.06 HAEMOPTYSIS | 6 0.06 46.12 HAEMORRHAGE | 14 0.14 46.26 HAEMORRHAGE INTRACRANIAL | 3 0.03 46.29 HAEMORRHAGE SUBCUTANEOUS | 2 0.02 46.31 HAEMORRHAGE URINARY TRACT | 2 0.02 46.33 HAEMORRHAGIC ANAEMIA | 1 0.01 46.34 HAEMORRHAGIC DIATHESIS | 1 0.01 46.35 HAEMORRHAGIC INFARCTION | 1 0.01 46.36 HAEMORRHAGIC STROKE | 3 0.03 46.39 HAEMORRHOIDAL HAEMORRHAGE | 1 0.01 46.40 HAEMORRHOIDS | 4 0.04 46.44 HAEMOTHORAX | 1 0.01 46.45 HALLUCINATION | 26 0.26 46.71 HALLUCINATION, AUDITORY | 1 0.01 46.72 HALLUCINATION, VISUAL | 7 0.07 46.79 HAND FRACTURE | 1 0.01 46.80 HEAD INJURY | 7 0.07 46.87 HEADACHE | 61 0.61 47.48 HEARING IMPAIRED | 2 0.02 47.50 HEART DISEASE CONGENITAL | 2 0.02 47.52 HEART INJURY | 1 0.01 47.53 HEART RATE ABNORMAL | 1 0.01 47.54 HEART RATE DECREASED | 8 0.08 47.62 HEART RATE INCREASED | 11 0.11 47.73 HEART RATE IRREGULAR | 6 0.06 47.79 HEART SOUNDS ABNORMAL | 2 0.02 47.81 HEART VALVE OPERATION | 1 0.01 47.82 HELICOBACTER GASTRITIS | 1 0.01 47.83 HELICOBACTER INFECTION | 1 0.01 47.84 HEMIANOPIA | 1 0.01 47.85 HEMIPARESIS | 4 0.04 47.89 HEMIPLEGIA | 5 0.05 47.94 HEPARIN-INDUCED THROMBOCYTOPENIA | 4 0.04 47.98 HEPATECTOMY | 1 0.01 47.99 HEPATIC CIRRHOSIS | 3 0.03 48.02 HEPATIC CONGESTION | 1 0.01 48.03 HEPATIC ENCEPHALOPATHY | 3 0.03 48.06 HEPATIC ENZYME ABNORMAL | 1 0.01 48.07 HEPATIC ENZYME INCREASED | 12 0.12 48.19 HEPATIC FAILURE | 14 0.14 48.33 HEPATIC FUNCTION ABNORMAL | 13 0.13 48.46 HEPATIC HAEMATOMA | 1 0.01 48.47 HEPATIC INFILTRATION EOSINOPHILIC | 1 0.01 48.48 HEPATIC NECROSIS | 2 0.02 48.50 HEPATIC NEOPLASM MALIGNANT | 4 0.04 48.54 HEPATIC PAIN | 2 0.02 48.56 HEPATIC STEATOSIS | 3 0.03 48.59 HEPATITIS | 18 0.18 48.77 HEPATITIS B | 3 0.03 48.80 HEPATITIS B VIRUS | 1 0.01 48.81 HEPATITIS C | 1 0.01 48.82 HEPATITIS CHOLESTATIC | 5 0.05 48.87 HEPATITIS CHRONIC ACTIVE | 1 0.01 48.88 HEPATITIS FULMINANT | 3 0.03 48.91 HEPATITIS TOXIC | 1 0.01 48.92 HEPATOCELLULAR DAMAGE | 3 0.03 48.95 HEPATOMEGALY | 1 0.01 48.96 HEPATORENAL FAILURE | 1 0.01 48.97 HEPATORENAL SYNDROME | 1 0.01 48.98 HEPATOSPLENOMEGALY | 2 0.02 49.00 HEPATOTOXICITY | 6 0.06 49.06 HERNIA | 1 0.01 49.07 HERNIA REPAIR | 2 0.02 49.09 HERPES SIMPLEX | 8 0.08 49.17 HERPES VIRUS INFECTION | 1 0.01 49.18 HERPES ZOSTER | 3 0.03 49.21 HERPES ZOSTER MULTI-DERMATOMAL | 1 0.01 49.22 HIATUS HERNIA | 3 0.03 49.25 HICCUPS | 1 0.01 49.26 HIGH TURNOVER OSTEOPATHY | 1 0.01 49.27 HIP ARTHROPLASTY | 1 0.01 49.28 HIP FRACTURE | 8 0.08 49.36 HIP SURGERY | 1 0.01 49.37 HIRSUTISM | 1 0.01 49.38 HISTIOCYTOSIS HAEMATOPHAGIC | 1 0.01 49.39 HISTOPLASMOSIS | 1 0.01 49.40 HIV INFECTION | 1 0.01 49.41 HODGKIN'S DISEASE | 1 0.01 49.42 HOMICIDE | 2 0.02 49.44 HOSPITALISATION | 7 0.07 49.51 HOSTILITY | 2 0.02 49.53 HOT FLUSH | 5 0.05 49.58 HUNGER | 1 0.01 49.59 HYDROCEPHALUS | 1 0.01 49.60 HYDRONEPHROSIS | 3 0.03 49.63 HYPERACUSIS | 1 0.01 49.64 HYPERADRENOCORTICISM | 1 0.01 49.65 HYPERAESTHESIA | 3 0.03 49.68 HYPERAMMONAEMIA | 1 0.01 49.69 HYPERAMYLASAEMIA | 1 0.01 49.70 HYPERBARIC OXYGEN THERAPY | 1 0.01 49.71 HYPERBILIRUBINAEMIA | 4 0.04 49.75 HYPERBILIRUBINAEMIA NEONATAL | 1 0.01 49.76 HYPERCHOLESTEROLAEMIA | 1 0.01 49.77 HYPERGAMMAGLOBULINAEMIA | 1 0.01 49.78 HYPERGLYCAEMIA | 15 0.15 49.93 HYPERHIDROSIS | 26 0.26 50.19 HYPERKALAEMIA | 8 0.08 50.27 HYPERLIPIDAEMIA | 5 0.05 50.32 HYPERNATRAEMIA | 2 0.02 50.34 HYPERPARATHYROIDISM | 1 0.01 50.35 HYPERPLASIA | 1 0.01 50.36 HYPERSENSITIVITY | 29 0.29 50.65 HYPERSOMNIA | 5 0.05 50.70 HYPERTENSION | 40 0.40 51.10 HYPERTENSIVE CRISIS | 3 0.03 51.13 HYPERTHERMIA | 2 0.02 51.15 HYPERTHYROIDISM | 5 0.05 51.20 HYPERTONIC BLADDER | 2 0.02 51.22 HYPERTRICHOSIS | 1 0.01 51.23 HYPERTRIGLYCERIDAEMIA | 1 0.01 51.24 HYPERVENTILATION | 3 0.03 51.27 HYPOACUSIS | 3 0.03 51.30 HYPOAESTHESIA | 18 0.18 51.48 HYPOAESTHESIA FACIAL | 1 0.01 51.49 HYPOAESTHESIA ORAL | 2 0.02 51.51 HYPOALBUMINAEMIA | 2 0.02 51.53 HYPOCALCAEMIA | 4 0.04 51.57 HYPOGAMMAGLOBULINAEMIA | 2 0.02 51.59 HYPOGLYCAEMIA | 26 0.26 51.85 HYPOGLYCAEMIC COMA | 2 0.02 51.87 HYPOGLYCAEMIC SEIZURE | 1 0.01 51.88 HYPOGLYCAEMIC UNCONSCIOUSNESS | 1 0.01 51.89 HYPOKALAEMIA | 15 0.15 52.04 HYPOKINESIA | 3 0.03 52.07 HYPOMAGNESAEMIA | 4 0.04 52.11 HYPOMANIA | 1 0.01 52.12 HYPONATRAEMIA | 17 0.17 52.29 HYPOPHOSPHATAEMIA | 3 0.03 52.32 HYPOPLASTIC LEFT HEART SYNDROME | 2 0.02 52.34 HYPOPNOEA | 1 0.01 52.35 HYPOSMIA | 1 0.01 52.36 HYPOSPADIAS | 2 0.02 52.38 HYPOTENSION | 34 0.34 52.72 HYPOTHALAMO-PITUITARY DISORDER | 1 0.01 52.73 HYPOTHERMIA | 6 0.06 52.79 HYPOTHYROIDISM | 6 0.06 52.85 HYPOTONIA | 4 0.04 52.89 HYPOTONIA NEONATAL | 2 0.02 52.91 HYPOTONIC URINARY BLADDER | 1 0.01 52.92 HYPOVENTILATION | 4 0.04 52.96 HYPOXIA | 5 0.05 53.01 HYPOXIC ENCEPHALOPATHY | 2 0.02 53.03 HYSTEROSALPINGO-OOPHORECTOMY | 1 0.01 53.04 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 2 0.02 53.06 ILEITIS | 1 0.01 53.07 ILEUS | 7 0.07 53.14 ILEUS PARALYTIC | 3 0.03 53.17 ILIAC ARTERY THROMBOSIS | 2 0.02 53.19 ILL-DEFINED DISORDER | 10 0.10 53.29 ILLUSION | 1 0.01 53.30 IMMOBILE | 2 0.02 53.32 IMMUNE RECONSTITUTION SYNDROME | 7 0.07 53.39 IMMUNODEFICIENCY | 1 0.01 53.40 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED | 1 0.01 53.41 IMMUNOSUPPRESSANT DRUG THERAPY | 1 0.01 53.42 IMMUNOSUPPRESSION | 1 0.01 53.43 IMPAIRED DRIVING ABILITY | 7 0.07 53.50 IMPAIRED HEALING | 7 0.07 53.57 IMPAIRED WORK ABILITY | 3 0.03 53.60 IMPLANTABLE DEFIBRILLATOR INSERTION | 2 0.02 53.62 IMPULSIVE BEHAVIOUR | 1 0.01 53.63 INADEQUATE ANALGESIA | 1 0.01 53.64 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 4 0.04 53.68 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 4 0.04 53.72 INCISION SITE ERYTHEMA | 1 0.01 53.73 INCISION SITE INFECTION | 1 0.01 53.74 INCISION SITE OEDEMA | 1 0.01 53.75 INCISIONAL DRAINAGE | 1 0.01 53.76 INCOHERENT | 1 0.01 53.77 INCONTINENCE | 3 0.03 53.80 INCORRECT DOSE ADMINISTERED | 6 0.06 53.86 INCORRECT DRUG ADMINISTRATION RATE | 2 0.02 53.88 INCORRECT DRUG DOSAGE FORM ADMINISTERED | 1 0.01 53.89 INCORRECT ROUTE OF DRUG ADMINISTRATION | 1 0.01 53.90 INCREASED APPETITE | 2 0.02 53.92 INCREASED TENDENCY TO BRUISE | 2 0.02 53.94 INFARCTION | 3 0.03 53.97 INFECTED LYMPHOCELE | 1 0.01 53.98 INFECTION | 21 0.21 54.19 INFECTION IN AN IMMUNOCOMPROMISED HOST | 1 0.01 54.20 INFECTIOUS MONONUCLEOSIS | 1 0.01 54.21 INFERTILITY FEMALE | 2 0.02 54.23 INFLAMMATION | 4 0.04 54.27 INFLAMMATORY BOWEL DISEASE | 8 0.08 54.35 INFLUENZA | 5 0.05 54.40 INFLUENZA LIKE ILLNESS | 6 0.06 54.46 INFUSION RELATED REACTION | 5 0.05 54.51 INFUSION SITE REACTION | 1 0.01 54.52 INITIAL INSOMNIA | 1 0.01 54.53 INJECTION SITE DESQUAMATION | 1 0.01 54.54 INJECTION SITE ERYTHEMA | 1 0.01 54.55 INJECTION SITE EXTRAVASATION | 1 0.01 54.56 INJECTION SITE HAEMATOMA | 1 0.01 54.57 INJECTION SITE HAEMORRHAGE | 1 0.01 54.58 INJECTION SITE INDURATION | 1 0.01 54.59 INJECTION SITE NECROSIS | 1 0.01 54.60 INJECTION SITE PAIN | 3 0.03 54.63 INJECTION SITE REACTION | 3 0.03 54.66 INJURY | 10 0.10 54.76 INJURY ASPHYXIATION | 1 0.01 54.77 INSOMNIA | 32 0.32 55.09 INSULIN-REQUIRING TYPE II DIABETES ME.. | 2 0.02 55.11 INSULINOMA | 1 0.01 55.12 INTENSIVE CARE | 1 0.01 55.13 INTENTIONAL DRUG MISUSE | 7 0.07 55.20 INTENTIONAL OVERDOSE | 16 0.16 55.36 INTERMITTENT CLAUDICATION | 1 0.01 55.37 INTERNATIONAL NORMALISED RATIO INCREA.. | 6 0.06 55.43 INTERRUPTION OF AORTIC ARCH | 1 0.01 55.44 INTERSTITIAL LUNG DISEASE | 14 0.14 55.58 INTERVERTEBRAL DISC COMPRESSION | 1 0.01 55.59 INTERVERTEBRAL DISC DEGENERATION | 2 0.02 55.61 INTERVERTEBRAL DISC DISORDER | 1 0.01 55.62 INTERVERTEBRAL DISC PROTRUSION | 4 0.04 55.66 INTESTINAL FISTULA | 1 0.01 55.67 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 55.68 INTESTINAL HAEMORRHAGE | 4 0.04 55.72 INTESTINAL ISCHAEMIA | 4 0.04 55.76 INTESTINAL OBSTRUCTION | 12 0.12 55.88 INTESTINAL OPERATION | 1 0.01 55.89 INTESTINAL PERFORATION | 2 0.02 55.91 INTESTINAL RESECTION | 1 0.01 55.92 INTESTINAL ULCER | 1 0.01 55.93 INTRA-UTERINE CONTRACEPTIVE DEVICE EX.. | 1 0.01 55.94 INTRA-UTERINE DEATH | 2 0.02 55.96 INTRACRANIAL PRESSURE INCREASED | 1 0.01 55.97 INTRAOCULAR PRESSURE INCREASED | 11 0.11 56.08 INTRAVENTRICULAR HAEMORRHAGE | 2 0.02 56.10 INTRAVENTRICULAR HAEMORRHAGE NEONATAL | 1 0.01 56.11 INTUBATION | 2 0.02 56.13 IRIDOCELE | 1 0.01 56.14 IRIDOCYCLITIS | 1 0.01 56.15 IRIS ATROPHY | 1 0.01 56.16 IRIS HYPOPIGMENTATION | 1 0.01 56.17 IRIS TRANSILLUMINATION DEFECT | 1 0.01 56.18 IRITIS | 2 0.02 56.20 IRON BINDING CAPACITY TOTAL DECREASED | 1 0.01 56.21 IRON DEFICIENCY ANAEMIA | 2 0.02 56.23 IRRITABILITY | 11 0.11 56.34 IRRITABLE BOWEL SYNDROME | 5 0.05 56.39 ISCHAEMIA | 2 0.02 56.41 ISCHAEMIC CEREBRAL INFARCTION | 4 0.04 56.45 ISCHAEMIC STROKE | 9 0.09 56.54 JAUNDICE | 23 0.23 56.77 JAUNDICE CHOLESTATIC | 3 0.03 56.80 JAW DISORDER | 3 0.03 56.83 JAW OPERATION | 1 0.01 56.84 JOINT DISLOCATION | 1 0.01 56.85 JOINT EFFUSION | 1 0.01 56.86 JOINT INJURY | 4 0.04 56.90 JOINT INSTABILITY | 1 0.01 56.91 JOINT SPRAIN | 2 0.02 56.93 JOINT STIFFNESS | 1 0.01 56.94 JOINT SWELLING | 5 0.05 56.99 JUVENILE ARTHRITIS | 4 0.04 57.03 KAOLIN CEPHALIN CLOTTING TIME PROLONGED | 1 0.01 57.04 KAPOSI'S SARCOMA | 1 0.01 57.05 KERATITIS | 2 0.02 57.07 KETOACIDOSIS | 7 0.07 57.14 KETONURIA | 1 0.01 57.15 KIDNEY ENLARGEMENT | 1 0.01 57.16 KIDNEY TRANSPLANT REJECTION | 1 0.01 57.17 KNEE ARTHROPLASTY | 2 0.02 57.19 KNEE DEFORMITY | 2 0.02 57.21 KNEE OPERATION | 1 0.01 57.22 LABORATORY TEST ABNORMAL | 6 0.06 57.28 LABYRINTHITIS | 1 0.01 57.29 LACERATION | 1 0.01 57.30 LACRIMATION INCREASED | 4 0.04 57.34 LACTIC ACIDOSIS | 13 0.13 57.47 LAPAROSCOPY | 1 0.01 57.48 LAPAROTOMY | 1 0.01 57.49 LARGE INTESTINAL HAEMORRHAGE | 1 0.01 57.50 LARGE INTESTINAL OBSTRUCTION | 1 0.01 57.51 LARGE INTESTINAL ULCER | 1 0.01 57.52 LARGE INTESTINE CARCINOMA | 1 0.01 57.53 LARYNGEAL CANCER | 1 0.01 57.54 LARYNGEAL OEDEMA | 5 0.05 57.59 LARYNGEAL STENOSIS | 1 0.01 57.60 LARYNGITIS | 2 0.02 57.62 LARYNGOSPASM | 3 0.03 57.65 LAZINESS | 1 0.01 57.66 LEFT VENTRICULAR FAILURE | 2 0.02 57.68 LEG AMPUTATION | 2 0.02 57.70 LEGIONELLA INFECTION | 2 0.02 57.72 LETHARGY | 12 0.12 57.84 LEUKAEMIA | 1 0.01 57.85 LEUKAEMIA RECURRENT | 1 0.01 57.86 LEUKOCYTOCLASTIC VASCULITIS | 2 0.02 57.88 LEUKOCYTOSIS | 5 0.05 57.93 LEUKOENCEPHALOMYELITIS | 1 0.01 57.94 LEUKOENCEPHALOPATHY | 3 0.03 57.97 LEUKOPENIA | 19 0.19 58.16 LIBIDO DECREASED | 3 0.03 58.19 LIBIDO INCREASED | 1 0.01 58.20 LIFE SUPPORT | 2 0.02 58.22 LIGAMENT SPRAIN | 1 0.01 58.23 LIMB DISCOMFORT | 2 0.02 58.25 LIMB INJURY | 2 0.02 58.27 LIP DISORDER | 2 0.02 58.29 LIP HAEMATOMA | 1 0.01 58.30 LIP HAEMORRHAGE | 1 0.01 58.31 LIP OEDEMA | 2 0.02 58.33 LIP SWELLING | 9 0.09 58.42 LIPASE INCREASED | 2 0.02 58.44 LIPODYSTROPHY ACQUIRED | 4 0.04 58.48 LIPOMA | 2 0.02 58.50 LIPOMATOSIS | 1 0.01 58.51 LIPOSARCOMA | 1 0.01 58.52 LIPOSUCTION | 1 0.01 58.53 LIVEDO RETICULARIS | 1 0.01 58.54 LIVER DISORDER | 22 0.22 58.76 LIVER FUNCTION TEST ABNORMAL | 14 0.14 58.90 LIVER INJURY | 1 0.01 58.91 LIVER TRANSPLANT | 1 0.01 58.92 LIVER TRANSPLANT REJECTION | 1 0.01 58.93 LOBAR PNEUMONIA | 3 0.03 58.96 LOCAL SWELLING | 3 0.03 58.99 LOCALISED INFECTION | 1 0.01 59.00 LONG QT SYNDROME | 2 0.02 59.02 LOOSE TOOTH | 1 0.01 59.03 LOSS OF CONSCIOUSNESS | 56 0.56 59.59 LOSS OF LIBIDO | 2 0.02 59.61 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 59.62 LOWER EXTREMITY MASS | 1 0.01 59.63 LOWER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 59.64 LOWER LIMB FRACTURE | 1 0.01 59.65 LOWER RESPIRATORY TRACT INFECTION | 4 0.04 59.69 LUMBAR PUNCTURE ABNORMAL | 1 0.01 59.70 LUMBAR VERTEBRAL FRACTURE | 1 0.01 59.71 LUNG ADENOCARCINOMA | 1 0.01 59.72 LUNG CANCER METASTATIC | 2 0.02 59.74 LUNG CONSOLIDATION | 1 0.01 59.75 LUNG DISORDER | 9 0.09 59.84 LUNG INFECTION | 4 0.04 59.88 LUNG INFILTRATION | 4 0.04 59.92 LUNG INJURY | 1 0.01 59.93 LUNG NEOPLASM | 3 0.03 59.96 LUNG NEOPLASM MALIGNANT | 3 0.03 59.99 LUPUS-LIKE SYNDROME | 3 0.03 60.02 LYMPH NODE PAIN | 2 0.02 60.04 LYMPHADENECTOMY | 1 0.01 60.05 LYMPHADENITIS | 1 0.01 60.06 LYMPHADENOPATHY | 9 0.09 60.15 LYMPHOCELE MARSUPIALISATION | 1 0.01 60.16 LYMPHOCYTE COUNT DECREASED | 1 0.01 60.17 LYMPHOCYTE MORPHOLOGY ABNORMAL | 1 0.01 60.18 LYMPHOCYTE STIMULATION TEST POSITIVE | 3 0.03 60.21 LYMPHOCYTIC LEUKAEMIA | 1 0.01 60.22 LYMPHOEDEMA | 2 0.02 60.24 LYMPHOMA | 2 0.02 60.26 LYMPHOPENIA | 5 0.05 60.31 LYMPHOPROLIFERATIVE DISORDER | 2 0.02 60.33 MACROSOMIA | 1 0.01 60.34 MACULAR DEGENERATION | 1 0.01 60.35 MACULAR OEDEMA | 2 0.02 60.37 MACULOPATHY | 1 0.01 60.38 MAJOR DEPRESSION | 2 0.02 60.40 MALABSORPTION | 1 0.01 60.41 MALAISE | 54 0.54 60.95 MALARIA | 1 0.01 60.96 MALIGNANT BREAST LUMP REMOVAL | 1 0.01 60.97 MALIGNANT HYPERTENSION | 1 0.01 60.98 MALIGNANT MELANOMA | 2 0.02 61.00 MALIGNANT NEOPLASM PROGRESSION | 22 0.22 61.22 MALLORY-WEISS SYNDROME | 2 0.02 61.24 MALNUTRITION | 2 0.02 61.26 MANIA | 5 0.05 61.31 MARASMUS | 1 0.01 61.32 MASS | 3 0.03 61.35 MASS EXCISION | 1 0.01 61.36 MASTECTOMY | 1 0.01 61.37 MASTICATION DISORDER | 1 0.01 61.38 MASTOIDITIS | 2 0.02 61.40 MAXILLOFACIAL OPERATION | 1 0.01 61.41 MECONIUM STAIN | 1 0.01 61.42 MEDICAL DEVICE COMPLICATION | 1 0.01 61.43 MEDICATION ERROR | 13 0.13 61.56 MEGACOLON | 3 0.03 61.59 MELAENA | 5 0.05 61.64 MEMORY IMPAIRMENT | 11 0.11 61.75 MENIERE'S DISEASE | 1 0.01 61.76 MENINGIOMA BENIGN | 1 0.01 61.77 MENINGITIS | 3 0.03 61.80 MENINGITIS ASEPTIC | 4 0.04 61.84 MENINGITIS MENINGOCOCCAL | 1 0.01 61.85 MENOPAUSAL SYMPTOMS | 1 0.01 61.86 MENORRHAGIA | 3 0.03 61.89 MENSTRUATION IRREGULAR | 2 0.02 61.91 MENTAL DISORDER | 9 0.09 62.00 MENTAL DISORDER DUE TO A GENERAL MEDI.. | 1 0.01 62.01 MENTAL IMPAIRMENT | 3 0.03 62.04 MENTAL RETARDATION SEVERITY UNSPECIFIED | 2 0.02 62.06 MENTAL STATUS CHANGES | 5 0.05 62.11 MESANGIOPROLIFERATIVE GLOMERULONEPHRI.. | 1 0.01 62.12 METABOLIC ACIDOSIS | 4 0.04 62.16 METABOLIC DISORDER | 1 0.01 62.17 METABOLIC ENCEPHALOPATHY | 1 0.01 62.18 METAL POISONING | 1 0.01 62.19 METAMYELOCYTE COUNT INCREASED | 1 0.01 62.20 METASTASES TO BONE | 2 0.02 62.22 METASTASES TO CENTRAL NERVOUS SYSTEM | 4 0.04 62.26 METASTASES TO LIVER | 2 0.02 62.28 METASTASES TO LUNG | 2 0.02 62.30 METASTASES TO NERVOUS SYSTEM | 1 0.01 62.31 METASTASES TO SPINE | 1 0.01 62.32 METASTATIC NEOPLASM | 2 0.02 62.34 METASTATIC RENAL CELL CARCINOMA | 3 0.03 62.37 METHAEMOGLOBINAEMIA | 1 0.01 62.38 METRORRHAGIA | 2 0.02 62.40 MICROANGIOPATHY | 1 0.01 62.41 MICROTIA | 1 0.01 62.42 MICTURITION DISORDER | 3 0.03 62.45 MICTURITION FREQUENCY DECREASED | 1 0.01 62.46 MICTURITION URGENCY | 2 0.02 62.48 MIDDLE EAR EFFUSION | 1 0.01 62.49 MIDDLE INSOMNIA | 1 0.01 62.50 MIGRAINE | 10 0.10 62.60 MIGRAINE WITH AURA | 1 0.01 62.61 MIOSIS | 3 0.03 62.64 MITOCHONDRIAL TOXICITY | 1 0.01 62.65 MITRAL VALVE DISEASE | 2 0.02 62.67 MITRAL VALVE INCOMPETENCE | 8 0.08 62.75 MIXED HEPATOCELLULAR-CHOLESTATIC INJURY | 2 0.02 62.77 MOBILITY DECREASED | 7 0.07 62.84 MONOCYTE COUNT ABNORMAL | 1 0.01 62.85 MONOCYTE COUNT DECREASED | 1 0.01 62.86 MONOPARESIS | 1 0.01 62.87 MOOD ALTERED | 6 0.06 62.93 MOOD SWINGS | 1 0.01 62.94 MOTOR DYSFUNCTION | 1 0.01 62.95 MOUTH HAEMORRHAGE | 1 0.01 62.96 MOUTH PLAQUE | 1 0.01 62.97 MOUTH ULCERATION | 6 0.06 63.03 MOVEMENT DISORDER | 4 0.04 63.07 MUCOSAL INFLAMMATION | 9 0.09 63.16 MUCOUS MEMBRANE DISORDER | 1 0.01 63.17 MULTI-ORGAN DISORDER | 1 0.01 63.18 MULTI-ORGAN FAILURE | 22 0.22 63.40 MULTIPLE ALLERGIES | 1 0.01 63.41 MULTIPLE CONGENITAL ABNORMALITIES | 1 0.01 63.42 MULTIPLE DRUG OVERDOSE | 5 0.05 63.47 MULTIPLE DRUG OVERDOSE INTENTIONAL | 2 0.02 63.49 MULTIPLE INJURIES | 1 0.01 63.50 MULTIPLE PREGNANCY | 1 0.01 63.51 MULTIPLE SCLEROSIS | 5 0.05 63.56 MUSCLE ATROPHY | 1 0.01 63.57 MUSCLE CONTRACTIONS INVOLUNTARY | 1 0.01 63.58 MUSCLE DISORDER | 3 0.03 63.61 MUSCLE ENZYME INCREASED | 1 0.01 63.62 MUSCLE FATIGUE | 1 0.01 63.63 MUSCLE FIBROSIS | 1 0.01 63.64 MUSCLE HAEMORRHAGE | 1 0.01 63.65 MUSCLE INJURY | 2 0.02 63.67 MUSCLE RIGIDITY | 2 0.02 63.69 MUSCLE SPASMS | 26 0.26 63.95 MUSCLE SPASTICITY | 1 0.01 63.96 MUSCLE STRAIN | 1 0.01 63.97 MUSCLE TIGHTNESS | 1 0.01 63.98 MUSCLE TWITCHING | 1 0.01 63.99 MUSCULAR DYSTROPHY | 1 0.01 64.00 MUSCULAR WEAKNESS | 19 0.19 64.19 MUSCULOSKELETAL CHEST PAIN | 2 0.02 64.21 MUSCULOSKELETAL DISCOMFORT | 2 0.02 64.23 MUSCULOSKELETAL DISORDER | 1 0.01 64.24 MUSCULOSKELETAL PAIN | 13 0.13 64.37 MUSCULOSKELETAL STIFFNESS | 8 0.08 64.45 MUTISM | 2 0.02 64.47 MYALGIA | 37 0.37 64.84 MYASTHENIA GRAVIS | 1 0.01 64.85 MYCOBACTERIAL INFECTION | 1 0.01 64.86 MYCOSIS FUNGOIDES | 2 0.02 64.88 MYDRIASIS | 7 0.07 64.95 MYELITIS | 2 0.02 64.97 MYELOCYTE COUNT INCREASED | 1 0.01 64.98 MYELODYSPLASTIC SYNDROME | 3 0.03 65.01 MYELOFIBROSIS | 1 0.01 65.02 MYELOID LEUKAEMIA | 1 0.01 65.03 MYELOPATHY | 3 0.03 65.06 MYOCARDIAL FIBROSIS | 1 0.01 65.07 MYOCARDIAL INFARCTION | 67 0.67 65.74 MYOCARDIAL ISCHAEMIA | 3 0.03 65.77 MYOCARDITIS | 2 0.02 65.79 MYOCLONUS | 6 0.06 65.85 MYOGLOBIN BLOOD INCREASED | 2 0.02 65.87 MYOPATHY | 1 0.01 65.88 MYOPIA | 1 0.01 65.89 MYOSITIS | 3 0.03 65.92 NAIL DISORDER | 2 0.02 65.94 NARCISSISTIC PERSONALITY DISORDER | 1 0.01 65.95 NARCOLEPSY | 1 0.01 65.96 NARCOTIC INTOXICATION | 1 0.01 65.97 NASAL CONGESTION | 5 0.05 66.02 NASAL CYST | 1 0.01 66.03 NASAL DISORDER | 1 0.01 66.04 NASAL DRYNESS | 1 0.01 66.05 NASAL ULCER | 2 0.02 66.07 NASOPHARYNGITIS | 7 0.07 66.14 NAUSEA | 110 1.10 67.24 NECK INJURY | 2 0.02 67.26 NECK PAIN | 11 0.11 67.37 NECROSIS | 2 0.02 67.39 NECROTISING COLITIS | 2 0.02 67.41 NECROTISING FASCIITIS | 1 0.01 67.42 NEGATIVE THOUGHTS | 1 0.01 67.43 NEONATAL DISORDER | 2 0.02 67.45 NEONATAL RESPIRATORY DISTRESS SYNDROME | 2 0.02 67.47 NEONATAL RESPIRATORY FAILURE | 1 0.01 67.48 NEOPLASM MALIGNANT | 3 0.03 67.51 NEOPLASM PROGRESSION | 1 0.01 67.52 NEOPLASM RECURRENCE | 1 0.01 67.53 NEPHRECTOMY | 1 0.01 67.54 NEPHRITIS | 1 0.01 67.55 NEPHRITIS INTERSTITIAL | 4 0.04 67.59 NEPHROGENIC FIBROSING DERMOPATHY | 3 0.03 67.62 NEPHROLITHIASIS | 5 0.05 67.67 NEPHROPATHY | 2 0.02 67.69 NEPHROPATHY TOXIC | 3 0.03 67.72 NEPHROSCLEROSIS | 1 0.01 67.73 NEPHROSTOMY | 1 0.01 67.74 NEPHROTIC SYNDROME | 3 0.03 67.77 NERVE BLOCK | 1 0.01 67.78 NERVE COMPRESSION | 2 0.02 67.80 NERVE INJURY | 5 0.05 67.85 NERVOUS SYSTEM DISORDER | 12 0.12 67.97 NERVOUSNESS | 7 0.07 68.04 NEURALGIA | 5 0.05 68.09 NEURODERMATITIS | 1 0.01 68.10 NEUROGENIC BLADDER | 1 0.01 68.11 NEUROLEPTIC MALIGNANT SYNDROME | 5 0.05 68.16 NEUROLOGICAL INFECTION | 1 0.01 68.17 NEUROLOGICAL SYMPTOM | 3 0.03 68.20 NEUROPATHY | 7 0.07 68.27 NEUROPATHY PERIPHERAL | 5 0.05 68.32 NEUROPSYCHOLOGICAL TEST ABNORMAL | 1 0.01 68.33 NEUROSIS | 1 0.01 68.34 NEUROTOXICITY | 2 0.02 68.36 NEUTROPENIA | 26 0.26 68.62 NEUTROPENIC SEPSIS | 6 0.06 68.68 NEUTROPHIL COUNT ABNORMAL | 1 0.01 68.69 NEUTROPHIL COUNT DECREASED | 7 0.07 68.76 NEUTROPHIL COUNT INCREASED | 2 0.02 68.78 NEUTROPHIL PERCENTAGE INCREASED | 1 0.01 68.79 NIGHT BLINDNESS | 2 0.02 68.81 NIGHT SWEATS | 4 0.04 68.85 NIGHTMARE | 2 0.02 68.87 NO ADVERSE EFFECT | 3 0.03 68.90 NO THERAPEUTIC RESPONSE | 4 0.04 68.94 NOCTURIA | 4 0.04 68.98 NODAL RHYTHM | 2 0.02 69.00 NON-CARDIAC CHEST PAIN | 1 0.01 69.01 NON-HODGKIN'S LYMPHOMA | 1 0.01 69.02 NON-SMALL CELL LUNG CANCER | 1 0.01 69.03 NONSPECIFIC REACTION | 2 0.02 69.05 NORMOCHROMIC NORMOCYTIC ANAEMIA | 2 0.02 69.07 NUCHAL RIGIDITY | 1 0.01 69.08 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 1 0.01 69.09 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 1 0.01 69.10 NYSTAGMUS | 3 0.03 69.13 OBESITY | 5 0.05 69.18 OBLITERATIVE BRONCHIOLITIS | 2 0.02 69.20 OBSESSIVE THOUGHTS | 2 0.02 69.22 OBSESSIVE-COMPULSIVE DISORDER | 4 0.04 69.26 OBSTETRICAL PULMONARY EMBOLISM | 2 0.02 69.28 OBSTRUCTION | 1 0.01 69.29 OBSTRUCTIVE AIRWAYS DISORDER | 3 0.03 69.32 OCCULT BLOOD POSITIVE | 1 0.01 69.33 OCULAR DISCOMFORT | 1 0.01 69.34 OCULAR HYPERAEMIA | 6 0.06 69.40 OCULAR HYPERTENSION | 1 0.01 69.41 OCULAR ICTERUS | 1 0.01 69.42 OCULOGYRATION | 1 0.01 69.43 OCULOMUCOCUTANEOUS SYNDROME | 1 0.01 69.44 ODYNOPHAGIA | 2 0.02 69.46 OEDEMA | 14 0.14 69.60 OEDEMA GENITAL | 1 0.01 69.61 OEDEMA MOUTH | 3 0.03 69.64 OEDEMA PERIPHERAL | 41 0.41 70.05 OESOPHAGEAL CANDIDIASIS | 2 0.02 70.07 OESOPHAGEAL CARCINOMA | 2 0.02 70.09 OESOPHAGEAL DILATATION | 1 0.01 70.10 OESOPHAGEAL DISORDER | 2 0.02 70.12 OESOPHAGEAL PAIN | 2 0.02 70.14 OESOPHAGEAL STENOSIS | 1 0.01 70.15 OESOPHAGEAL VARICES HAEMORRHAGE | 1 0.01 70.16 OESOPHAGITIS | 3 0.03 70.19 OESOPHAGITIS HAEMORRHAGIC | 1 0.01 70.20 OESOPHAGITIS ULCERATIVE | 1 0.01 70.21 OESTROGEN RECEPTOR ASSAY POSITIVE | 1 0.01 70.22 OFF LABEL USE | 2 0.02 70.24 OILY SKIN | 1 0.01 70.25 OLIGURIA | 4 0.04 70.29 ONYCHOLYSIS | 1 0.01 70.30 OOPHORECTOMY | 2 0.02 70.32 OPEN WOUND | 4 0.04 70.36 OPISTHOTONUS | 1 0.01 70.37 OPPORTUNISTIC INFECTION | 5 0.05 70.42 OPTIC ISCHAEMIC NEUROPATHY | 2 0.02 70.44 OPTIC NERVE DISORDER | 1 0.01 70.45 OPTIC NERVE INFARCTION | 1 0.01 70.46 OPTIC NERVE INJURY | 1 0.01 70.47 OPTIC NEURITIS | 3 0.03 70.50 OPTIC NEUROPATHY | 1 0.01 70.51 ORAL CANDIDIASIS | 2 0.02 70.53 ORAL CAVITY FISTULA | 1 0.01 70.54 ORAL DISCOMFORT | 1 0.01 70.55 ORAL HERPES | 1 0.01 70.56 ORAL INFECTION | 1 0.01 70.57 ORAL INTAKE REDUCED | 6 0.06 70.63 ORAL MUCOSA EROSION | 1 0.01 70.64 ORAL MUCOSAL ERUPTION | 1 0.01 70.65 ORAL MUCOSAL EXFOLIATION | 2 0.02 70.67 ORAL PAIN | 3 0.03 70.70 ORAL PRURITUS | 1 0.01 70.71 ORAL SOFT TISSUE DISORDER | 1 0.01 70.72 ORGAN FAILURE | 1 0.01 70.73 ORTHOPNOEA | 1 0.01 70.74 ORTHOSTATIC HYPOTENSION | 7 0.07 70.81 OSTEITIS | 1 0.01 70.82 OSTEOARTHRITIS | 8 0.08 70.90 OSTEOLYSIS | 2 0.02 70.92 OSTEOMALACIA | 1 0.01 70.93 OSTEOMYELITIS | 11 0.11 71.04 OSTEOMYELITIS CHRONIC | 1 0.01 71.05 OSTEONECROSIS | 40 0.40 71.45 OSTEOPENIA | 2 0.02 71.47 OSTEOPOROSIS | 9 0.09 71.56 OSTEOSCLEROSIS | 1 0.01 71.57 OSTEOSYNTHESIS | 1 0.01 71.58 OSTEOTOMY | 1 0.01 71.59 OTITIS EXTERNA | 1 0.01 71.60 OVARIAN CANCER | 1 0.01 71.61 OVARIAN CYST | 1 0.01 71.62 OVARIAN DISORDER | 1 0.01 71.63 OVERDOSE | 36 0.36 71.99 OVERWEIGHT | 2 0.02 72.01 OXYGEN SATURATION DECREASED | 11 0.11 72.12 PAIN | 58 0.58 72.70 PAIN IN EXTREMITY | 27 0.27 72.97 PAIN IN JAW | 6 0.06 73.03 PAIN OF SKIN | 1 0.01 73.04 PAINFUL ERECTION | 1 0.01 73.05 PAINFUL RESPIRATION | 1 0.01 73.06 PALATAL DISORDER | 2 0.02 73.08 PALATAL OEDEMA | 1 0.01 73.09 PALLOR | 7 0.07 73.16 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 6 0.06 73.22 PALPITATIONS | 18 0.18 73.40 PANCREATIC CARCINOMA | 1 0.01 73.41 PANCREATIC DISORDER | 1 0.01 73.42 PANCREATIC ENZYMES INCREASED | 1 0.01 73.43 PANCREATIC INSUFFICIENCY | 1 0.01 73.44 PANCREATIC NEOPLASM | 1 0.01 73.45 PANCREATIC PSEUDOCYST | 1 0.01 73.46 PANCREATITIS | 39 0.39 73.85 PANCREATITIS ACUTE | 4 0.04 73.89 PANCREATITIS CHRONIC | 1 0.01 73.90 PANCREATITIS RELAPSING | 1 0.01 73.91 PANCYTOPENIA | 13 0.13 74.04 PANIC ATTACK | 9 0.09 74.13 PANIC REACTION | 4 0.04 74.17 PANNICULITIS | 1 0.01 74.18 PAPILLITIS | 1 0.01 74.19 PAPILLOEDEMA | 2 0.02 74.21 PARAESTHESIA | 20 0.20 74.41 PARAESTHESIA MUCOSAL | 1 0.01 74.42 PARAESTHESIA ORAL | 2 0.02 74.44 PARALYSIS | 5 0.05 74.49 PARALYSIS FLACCID | 1 0.01 74.50 PARANEOPLASTIC SYNDROME | 1 0.01 74.51 PARANOIA | 6 0.06 74.57 PARAPARESIS | 1 0.01 74.58 PARATHYROID TUMOUR | 1 0.01 74.59 PARESIS | 1 0.01 74.60 PARKINSON'S DISEASE | 5 0.05 74.65 PARKINSONISM | 4 0.04 74.69 PAROSMIA | 2 0.02 74.71 PAROTITIS | 2 0.02 74.73 PARTIAL SEIZURES | 2 0.02 74.75 PATELLA FRACTURE | 1 0.01 74.76 PATENT DUCTUS ARTERIOSUS | 4 0.04 74.80 PATHOLOGICAL GAMBLING | 1 0.01 74.81 PCO2 DECREASED | 2 0.02 74.83 PELVIC FRACTURE | 3 0.03 74.86 PELVIC INFLAMMATORY DISEASE | 1 0.01 74.87 PELVIC PAIN | 3 0.03 74.90 PENILE ULCERATION | 1 0.01 74.91 PENIS DISORDER | 2 0.02 74.93 PEPTIC ULCER | 3 0.03 74.96 PERFORMANCE STATUS DECREASED | 5 0.05 75.01 PERICARDIAL DISEASE | 1 0.01 75.02 PERICARDIAL EFFUSION | 6 0.06 75.08 PERICARDITIS | 5 0.05 75.13 PERIODONTAL INFECTION | 1 0.01 75.14 PERIODONTAL OPERATION | 1 0.01 75.15 PERIODONTITIS | 2 0.02 75.17 PERIORBITAL HAEMATOMA | 1 0.01 75.18 PERIORBITAL OEDEMA | 1 0.01 75.19 PERIPHERAL COLDNESS | 4 0.04 75.23 PERIPHERAL ISCHAEMIA | 2 0.02 75.25 PERIPHERAL MOTOR NEUROPATHY | 1 0.01 75.26 PERIPHERAL SENSORY NEUROPATHY | 2 0.02 75.28 PERITONEAL CARCINOMA | 1 0.01 75.29 PERITONEAL DISORDER | 1 0.01 75.30 PERITONITIS | 7 0.07 75.37 PERITONITIS BACTERIAL | 5 0.05 75.42 PERSONALITY CHANGE | 3 0.03 75.45 PERSONALITY DISORDER | 2 0.02 75.47 PETECHIAE | 1 0.01 75.48 PETIT MAL EPILEPSY | 1 0.01 75.49 PHAGOPHOBIA | 1 0.01 75.50 PHARMACEUTICAL PRODUCT COMPLAINT | 31 0.31 75.81 PHARYNGEAL OEDEMA | 5 0.05 75.86 PHARYNGITIS | 3 0.03 75.89 PHARYNGITIS STREPTOCOCCAL | 1 0.01 75.90 PHARYNGOLARYNGEAL PAIN | 9 0.09 75.99 PHLEBITIS | 1 0.01 76.00 PHONOPHOBIA | 1 0.01 76.01 PHOTOPHOBIA | 4 0.04 76.05 PHOTOSENSITIVITY REACTION | 2 0.02 76.07 PHYSICAL ASSAULT | 1 0.01 76.08 PHYSICAL DISABILITY | 2 0.02 76.10 PHYSICAL EXAMINATION | 1 0.01 76.11 PIGMENTATION DISORDER | 1 0.01 76.12 PILONIDAL CYST CONGENITAL | 1 0.01 76.13 PITTING OEDEMA | 4 0.04 76.17 PITUITARY ENLARGEMENT | 1 0.01 76.18 PITYRIASIS | 2 0.02 76.20 PLACENTA PRAEVIA | 1 0.01 76.21 PLACENTA PRAEVIA HAEMORRHAGE | 1 0.01 76.22 PLACENTAL DISORDER | 2 0.02 76.24 PLANTAR FASCIITIS | 1 0.01 76.25 PLASMABLAST COUNT INCREASED | 1 0.01 76.26 PLATELET AGGREGATION DECREASED | 1 0.01 76.27 PLATELET COUNT DECREASED | 16 0.16 76.43 PLATELET COUNT INCREASED | 4 0.04 76.47 PLATELET FUNCTION TEST ABNORMAL | 1 0.01 76.48 PLEURAL ADHESION | 1 0.01 76.49 PLEURAL EFFUSION | 21 0.21 76.70 PLEURAL HAEMORRHAGE | 1 0.01 76.71 PLEURISY | 2 0.02 76.73 PLEURITIC PAIN | 2 0.02 76.75 PLEUROTHOTONUS | 3 0.03 76.78 PNEUMATOSIS INTESTINALIS | 3 0.03 76.81 PNEUMOCOCCAL BACTERAEMIA | 1 0.01 76.82 PNEUMOCYSTIS JIROVECI PNEUMONIA | 7 0.07 76.89 PNEUMOMEDIASTINUM | 1 0.01 76.90 PNEUMONIA | 53 0.53 77.43 PNEUMONIA ASPIRATION | 6 0.06 77.49 PNEUMONIA BACTERIAL | 1 0.01 77.50 PNEUMONIA KLEBSIELLA | 1 0.01 77.51 PNEUMONITIS | 4 0.04 77.55 PNEUMOPERITONEUM | 1 0.01 77.56 PO2 DECREASED | 3 0.03 77.59 POISONING | 3 0.03 77.62 POLLAKIURIA | 7 0.07 77.69 POLYARTHRITIS | 2 0.02 77.71 POLYCYSTIC OVARIES | 3 0.03 77.74 POLYDIPSIA | 1 0.01 77.75 POLYDIPSIA PSYCHOGENIC | 1 0.01 77.76 POLYHYDRAMNIOS | 1 0.01 77.77 POLYMYOSITIS | 2 0.02 77.79 POLYNEUROPATHY | 6 0.06 77.85 POLYP COLORECTAL | 1 0.01 77.86 POLYPECTOMY | 1 0.01 77.87 POLYSEROSITIS | 1 0.01 77.88 POOR PERIPHERAL CIRCULATION | 1 0.01 77.89 POOR QUALITY SLEEP | 1 0.01 77.90 POOR WEIGHT GAIN NEONATAL | 1 0.01 77.91 PORPHYRIA NON-ACUTE | 1 0.01 77.92 PORPHYRINS URINE INCREASED | 1 0.01 77.93 PORTAL VEIN THROMBOSIS | 1 0.01 77.94 POST CONCUSSION SYNDROME | 1 0.01 77.95 POST GASTRIC SURGERY SYNDROME | 1 0.01 77.96 POST HERPETIC NEURALGIA | 2 0.02 77.98 POST PROCEDURAL COMPLICATION | 2 0.02 78.00 POST PROCEDURAL HAEMATOMA | 1 0.01 78.01 POST PROCEDURAL HAEMORRHAGE | 1 0.01 78.02 POST-TRAUMATIC STRESS DISORDER | 3 0.03 78.05 POSTNASAL DRIP | 1 0.01 78.06 POSTOPERATIVE WOUND COMPLICATION | 1 0.01 78.07 POSTRENAL FAILURE | 1 0.01 78.08 PRE-ECLAMPSIA | 3 0.03 78.11 PRECOCIOUS PUBERTY | 1 0.01 78.12 PREGNANCY | 4 0.04 78.16 PREGNANCY ON ORAL CONTRACEPTIVE | 2 0.02 78.18 PREMATURE BABY | 5 0.05 78.23 PREMATURE LABOUR | 1 0.01 78.24 PRESCRIBED OVERDOSE | 2 0.02 78.26 PRESYNCOPE | 3 0.03 78.29 PRIAPISM | 3 0.03 78.32 PRIMARY HYPOTHYROIDISM | 1 0.01 78.33 PRIMARY SEQUESTRUM | 2 0.02 78.35 PROCEDURAL COMPLICATION | 3 0.03 78.38 PROCTALGIA | 1 0.01 78.39 PROCTITIS | 2 0.02 78.41 PRODUCTIVE COUGH | 5 0.05 78.46 PROGESTERONE RECEPTOR ASSAY POSITIVE | 1 0.01 78.47 PROSTATE CANCER | 4 0.04 78.51 PROSTATE EXAMINATION ABNORMAL | 1 0.01 78.52 PROSTATIC OPERATION | 1 0.01 78.53 PROSTATIC PAIN | 1 0.01 78.54 PROSTATITIS | 1 0.01 78.55 PROTEIN TOTAL DECREASED | 1 0.01 78.56 PROTEIN TOTAL INCREASED | 1 0.01 78.57 PROTEIN URINE PRESENT | 1 0.01 78.58 PROTEINURIA | 3 0.03 78.61 PROTHROMBIN LEVEL DECREASED | 3 0.03 78.64 PROTHROMBIN TIME PROLONGED | 4 0.04 78.68 PROTHROMBIN TIME SHORTENED | 1 0.01 78.69 PRURIGO | 1 0.01 78.70 PRURITUS | 44 0.44 79.14 PRURITUS GENERALISED | 3 0.03 79.17 PRURITUS GENITAL | 1 0.01 79.18 PSEUDOMEMBRANOUS COLITIS | 2 0.02 79.20 PSEUDOMONAS INFECTION | 2 0.02 79.22 PSORIASIS | 3 0.03 79.25 PSORIATIC ARTHROPATHY | 1 0.01 79.26 PSYCHIATRIC SYMPTOM | 6 0.06 79.32 PSYCHOMOTOR HYPERACTIVITY | 2 0.02 79.34 PSYCHOMOTOR RETARDATION | 1 0.01 79.35 PSYCHOPATHIC PERSONALITY | 1 0.01 79.36 PSYCHOTIC DISORDER | 14 0.14 79.50 PUBIC RAMI FRACTURE | 1 0.01 79.51 PULMONARY CONGESTION | 1 0.01 79.52 PULMONARY EMBOLISM | 20 0.20 79.72 PULMONARY FIBROSIS | 7 0.07 79.79 PULMONARY HAEMORRHAGE | 2 0.02 79.81 PULMONARY HYPERTENSION | 4 0.04 79.85 PULMONARY INFARCTION | 2 0.02 79.87 PULMONARY MASS | 1 0.01 79.88 PULMONARY MYCOSIS | 1 0.01 79.89 PULMONARY OEDEMA | 12 0.12 80.01 PULMONARY THROMBOSIS | 1 0.01 80.02 PULMONARY TOXICITY | 1 0.01 80.03 PULMONARY TUBERCULOSIS | 1 0.01 80.04 PULMONARY VALVE INCOMPETENCE | 1 0.01 80.05 PULMONARY VASCULAR DISORDER | 1 0.01 80.06 PULSE ABSENT | 4 0.04 80.10 PUPIL FIXED | 3 0.03 80.13 PUPILLARY REFLEX IMPAIRED | 2 0.02 80.15 PUPILS UNEQUAL | 1 0.01 80.16 PURPURA | 5 0.05 80.21 PURPURA SENILE | 1 0.01 80.22 PURULENT DISCHARGE | 4 0.04 80.26 PUSTULAR PSORIASIS | 1 0.01 80.27 PYELOCYSTITIS | 1 0.01 80.28 PYOMYOSITIS | 1 0.01 80.29 PYREXIA | 109 1.09 81.38 PYURIA | 1 0.01 81.39 QUADRIPARESIS | 1 0.01 81.40 RADIAL PULSE ABNORMAL | 1 0.01 81.41 RADIAL TUNNEL SYNDROME | 1 0.01 81.42 RADIATION PNEUMONITIS | 1 0.01 81.43 RADICULAR SYNDROME | 1 0.01 81.44 RADIOTHERAPY | 1 0.01 81.45 RALES | 3 0.03 81.48 RASH | 46 0.46 81.94 RASH ERYTHEMATOUS | 4 0.04 81.98 RASH GENERALISED | 10 0.10 82.08 RASH MACULAR | 5 0.05 82.13 RASH MACULO-PAPULAR | 16 0.16 82.29 RASH MORBILLIFORM | 2 0.02 82.31 RASH PAPULAR | 1 0.01 82.32 RASH PRURITIC | 7 0.07 82.39 RASH PUSTULAR | 1 0.01 82.40 RASH VESICULAR | 1 0.01 82.41 RAYNAUD'S PHENOMENON | 3 0.03 82.44 RECTAL HAEMORRHAGE | 11 0.11 82.55 RECTAL SPASM | 1 0.01 82.56 RECTAL STENOSIS | 1 0.01 82.57 RECTAL ULCER | 2 0.02 82.59 RED BLOOD CELL COUNT DECREASED | 5 0.05 82.64 RED BLOOD CELL SEDIMENTATION RATE INC.. | 5 0.05 82.69 RED BLOOD CELLS URINE POSITIVE | 1 0.01 82.70 REFLEXES ABNORMAL | 1 0.01 82.71 REFLUX GASTRITIS | 1 0.01 82.72 REFLUX OESOPHAGITIS | 2 0.02 82.74 REFRACTORY ANAEMIA | 1 0.01 82.75 REFUSAL OF TREATMENT BY PATIENT | 2 0.02 82.77 REGRESSIVE BEHAVIOUR | 1 0.01 82.78 REITER'S SYNDROME | 2 0.02 82.80 RENAL ABSCESS | 2 0.02 82.82 RENAL APLASIA | 2 0.02 82.84 RENAL ARTERY STENOSIS | 1 0.01 82.85 RENAL CELL CARCINOMA STAGE II | 1 0.01 82.86 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 4 0.04 82.90 RENAL COLIC | 1 0.01 82.91 RENAL CYST | 2 0.02 82.93 RENAL DISORDER | 4 0.04 82.97 RENAL FAILURE | 44 0.44 83.41 RENAL FAILURE ACUTE | 49 0.49 83.90 RENAL FAILURE CHRONIC | 5 0.05 83.95 RENAL IMPAIRMENT | 12 0.12 84.07 RENAL INFARCT | 2 0.02 84.09 RENAL PAPILLARY NECROSIS | 1 0.01 84.10 RENAL TUBULAR ACIDOSIS | 1 0.01 84.11 RENAL TUBULAR DISORDER | 2 0.02 84.13 RENAL TUBULAR NECROSIS | 1 0.01 84.14 RENIN INCREASED | 1 0.01 84.15 RESORPTION BONE INCREASED | 2 0.02 84.17 RESPIRATORY ACIDOSIS | 2 0.02 84.19 RESPIRATORY ARREST | 9 0.09 84.28 RESPIRATORY DEPRESSION | 2 0.02 84.30 RESPIRATORY DISORDER | 4 0.04 84.34 RESPIRATORY DISTRESS | 5 0.05 84.39 RESPIRATORY DYSKINESIA | 1 0.01 84.40 RESPIRATORY FAILURE | 18 0.18 84.58 RESPIRATORY RATE DECREASED | 1 0.01 84.59 RESPIRATORY RATE INCREASED | 2 0.02 84.61 RESPIRATORY TRACT CONGESTION | 1 0.01 84.62 RESPIRATORY TRACT INFECTION | 2 0.02 84.64 RESTLESS LEGS SYNDROME | 1 0.01 84.65 RESTLESSNESS | 8 0.08 84.73 RETCHING | 3 0.03 84.76 RETINAL DEPIGMENTATION | 2 0.02 84.78 RETINAL DETACHMENT | 5 0.05 84.83 RETINAL HAEMORRHAGE | 4 0.04 84.87 RETINAL OEDEMA | 1 0.01 84.88 RETINAL TEAR | 1 0.01 84.89 RETINAL TOXICITY | 1 0.01 84.90 RETINAL VASCULAR THROMBOSIS | 2 0.02 84.92 RETINAL VEIN OCCLUSION | 2 0.02 84.94 RETINAL VEIN THROMBOSIS | 1 0.01 84.95 RETROPERITONEAL FIBROSIS | 1 0.01 84.96 RETROPERITONEAL HAEMATOMA | 1 0.01 84.97 RETROVIRAL INFECTION | 1 0.01 84.98 REVERSIBLE POSTERIOR LEUKOENCEPHALOPA.. | 2 0.02 85.00 RHABDOMYOLYSIS | 27 0.27 85.27 RHEUMATOID ARTHRITIS | 5 0.05 85.32 RHEUMATOID FACTOR INCREASED | 2 0.02 85.34 RHINALGIA | 1 0.01 85.35 RHINITIS ALLERGIC | 1 0.01 85.36 RHINITIS SEASONAL | 1 0.01 85.37 RHINORRHOEA | 1 0.01 85.38 RHINOVIRUS INFECTION | 1 0.01 85.39 RHONCHI | 1 0.01 85.40 RIB FRACTURE | 5 0.05 85.45 RICKETS | 1 0.01 85.46 RIGHT VENTRICULAR FAILURE | 2 0.02 85.48 ROAD TRAFFIC ACCIDENT | 21 0.21 85.69 ROTATOR CUFF SYNDROME | 4 0.04 85.73 RUSSELL'S VIPER VENOM TIME ABNORMAL | 1 0.01 85.74 SACRAL HYPOPLASIA | 1 0.01 85.75 SALIVARY HYPERSECRETION | 5 0.05 85.80 SARCOIDOSIS | 2 0.02 85.82 SCAB | 1 0.01 85.83 SCAN ADRENAL GLAND ABNORMAL | 1 0.01 85.84 SCAR | 5 0.05 85.89 SCAR EXCISION | 1 0.01 85.90 SCHIZOAFFECTIVE DISORDER | 1 0.01 85.91 SCHIZOPHRENIA | 2 0.02 85.93 SCHIZOPHRENIA, DISORGANISED TYPE | 1 0.01 85.94 SCIATICA | 3 0.03 85.97 SCLERITIS | 1 0.01 85.98 SCLERODERMA | 1 0.01 85.99 SCLEROSING ENCAPSULATING PERITONITIS | 7 0.07 86.06 SCOLIOSIS | 2 0.02 86.08 SCREAMING | 1 0.01 86.09 SCROTAL ULCER | 1 0.01 86.10 SEASONAL ALLERGY | 1 0.01 86.11 SEDATION | 3 0.03 86.14 SELECTIVE IGG SUBCLASS DEFICIENCY | 1 0.01 86.15 SELF ESTEEM DECREASED | 2 0.02 86.17 SELF INJURIOUS BEHAVIOUR | 1 0.01 86.18 SELF-INJURIOUS IDEATION | 1 0.01 86.19 SELF-MEDICATION | 1 0.01 86.20 SENSATION OF FOREIGN BODY | 1 0.01 86.21 SENSATION OF HEAVINESS | 2 0.02 86.23 SENSE OF OPPRESSION | 1 0.01 86.24 SENSITIVITY OF TEETH | 1 0.01 86.25 SENSORIMOTOR DISORDER | 1 0.01 86.26 SENSORY DISTURBANCE | 2 0.02 86.28 SENSORY LOSS | 4 0.04 86.32 SEPSIS | 36 0.36 86.68 SEPSIS NEONATAL | 2 0.02 86.70 SEPSIS SYNDROME | 1 0.01 86.71 SEPTIC SHOCK | 15 0.15 86.86 SEQUESTRECTOMY | 3 0.03 86.89 SEROTONIN SYNDROME | 1 0.01 86.90 SERUM FERRITIN INCREASED | 4 0.04 86.94 SEVERE ACUTE RESPIRATORY SYNDROME | 1 0.01 86.95 SHOCK | 14 0.14 87.09 SHOCK HAEMORRHAGIC | 4 0.04 87.13 SHORT-BOWEL SYNDROME | 1 0.01 87.14 SIALOADENITIS | 1 0.01 87.15 SICK SINUS SYNDROME | 1 0.01 87.16 SIGMOIDITIS | 1 0.01 87.17 SINUS ARRHYTHMIA | 2 0.02 87.19 SINUS BRADYCARDIA | 1 0.01 87.20 SINUS CONGESTION | 1 0.01 87.21 SINUS DISORDER | 1 0.01 87.22 SINUS TACHYCARDIA | 4 0.04 87.26 SINUSITIS | 16 0.16 87.42 SJOGREN'S SYNDROME | 5 0.05 87.47 SKIN BURNING SENSATION | 2 0.02 87.49 SKIN CANCER | 1 0.01 87.50 SKIN DISCOLOURATION | 6 0.06 87.56 SKIN DISCOMFORT | 1 0.01 87.57 SKIN DISORDER | 3 0.03 87.60 SKIN EROSION | 1 0.01 87.61 SKIN EXFOLIATION | 7 0.07 87.68 SKIN GRAFT | 1 0.01 87.69 SKIN HAEMORRHAGE | 1 0.01 87.70 SKIN HYPERPIGMENTATION | 2 0.02 87.72 SKIN INFECTION | 2 0.02 87.74 SKIN IRRITATION | 1 0.01 87.75 SKIN LACERATION | 3 0.03 87.78 SKIN LESION | 2 0.02 87.80 SKIN NECROSIS | 5 0.05 87.85 SKIN OEDEMA | 2 0.02 87.87 SKIN REACTION | 1 0.01 87.88 SKIN STRIAE | 1 0.01 87.89 SKIN TOXICITY | 1 0.01 87.90 SKIN ULCER | 4 0.04 87.94 SLEEP APNOEA SYNDROME | 1 0.01 87.95 SLEEP ATTACKS | 1 0.01 87.96 SLEEP DISORDER | 11 0.11 88.07 SLEEP TALKING | 5 0.05 88.12 SLEEP TERROR | 2 0.02 88.14 SLEEP WALKING | 26 0.26 88.40 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 1 0.01 88.41 SMALL FOR DATES BABY | 2 0.02 88.43 SMALL INTESTINAL OBSTRUCTION | 4 0.04 88.47 SMALL INTESTINAL PERFORATION | 1 0.01 88.48 SMEAR CERVIX ABNORMAL | 1 0.01 88.49 SMOKER | 2 0.02 88.51 SNEEZING | 1 0.01 88.52 SOCIAL AVOIDANT BEHAVIOUR | 1 0.01 88.53 SOFT TISSUE INFECTION | 2 0.02 88.55 SOFT TISSUE INFLAMMATION | 1 0.01 88.56 SOMATISATION DISORDER | 1 0.01 88.57 SOMNOLENCE | 26 0.26 88.83 SOPOR | 2 0.02 88.85 SPECIFIC GRAVITY URINE INCREASED | 1 0.01 88.86 SPEECH DISORDER | 16 0.16 89.02 SPERMATOZOA PROGRESSIVE MOTILITY DECR.. | 1 0.01 89.03 SPINAL COLUMN STENOSIS | 3 0.03 89.06 SPINAL COMPRESSION FRACTURE | 3 0.03 89.09 SPINAL CORD DISORDER | 2 0.02 89.11 SPINAL CORD NEOPLASM | 1 0.01 89.12 SPINAL DISORDER | 1 0.01 89.13 SPINAL FRACTURE | 4 0.04 89.17 SPINAL OSTEOARTHRITIS | 2 0.02 89.19 SPLEEN SCAN ABNORMAL | 1 0.01 89.20 SPLENIC VEIN THROMBOSIS | 1 0.01 89.21 SPLENOMEGALY | 3 0.03 89.24 SPONDYLITIS | 1 0.01 89.25 SQUAMOUS CELL CARCINOMA | 1 0.01 89.26 STAPHYLOCOCCAL INFECTION | 2 0.02 89.28 STAPHYLOCOCCAL SEPSIS | 1 0.01 89.29 STAPHYLOCOCCAL SKIN INFECTION | 1 0.01 89.30 STATUS ASTHMATICUS | 1 0.01 89.31 STATUS EPILEPTICUS | 5 0.05 89.36 STEM CELL TRANSPLANT | 1 0.01 89.37 STENT PLACEMENT | 3 0.03 89.40 STEVENS-JOHNSON SYNDROME | 11 0.11 89.51 STILLBIRTH | 1 0.01 89.52 STOMACH DISCOMFORT | 10 0.10 89.62 STOMATITIS | 16 0.16 89.78 STOMATITIS NECROTISING | 1 0.01 89.79 STRABISMUS | 1 0.01 89.80 STREPTOCOCCAL INFECTION | 2 0.02 89.82 STRESS | 3 0.03 89.85 STRESS URINARY INCONTINENCE | 1 0.01 89.86 STRIDOR | 2 0.02 89.88 STUPOR | 1 0.01 89.89 SUBARACHNOID HAEMORRHAGE | 2 0.02 89.91 SUBCUTANEOUS ABSCESS | 1 0.01 89.92 SUBCUTANEOUS EMPHYSEMA | 1 0.01 89.93 SUBCUTANEOUS NODULE | 1 0.01 89.94 SUBDURAL HAEMATOMA | 2 0.02 89.96 SUBDURAL HAEMORRHAGE | 2 0.02 89.98 SUBILEUS | 1 0.01 89.99 SUBSTANCE ABUSE | 1 0.01 90.00 SUDDEN DEATH | 2 0.02 90.02 SUDDEN HEARING LOSS | 2 0.02 90.04 SUFFOCATION FEELING | 1 0.01 90.05 SUICIDAL BEHAVIOUR | 2 0.02 90.07 SUICIDAL IDEATION | 17 0.17 90.24 SUICIDE ATTEMPT | 30 0.30 90.54 SUPERIOR SAGITTAL SINUS THROMBOSIS | 1 0.01 90.55 SUPRAVENTRICULAR EXTRASYSTOLES | 4 0.04 90.59 SUPRAVENTRICULAR TACHYCARDIA | 4 0.04 90.63 SURGERY | 16 0.16 90.79 SUSPICIOUSNESS | 1 0.01 90.80 SWELLING | 8 0.08 90.88 SWELLING FACE | 10 0.10 90.98 SWOLLEN TONGUE | 12 0.12 91.10 SYNCOPE | 19 0.19 91.29 SYNCOPE VASOVAGAL | 2 0.02 91.31 SYNDACTYLY | 1 0.01 91.32 SYNOVIAL CYST | 1 0.01 91.33 SYSTEMIC LUPUS ERYTHEMATOSUS | 3 0.03 91.36 T-CELL LYMPHOMA | 1 0.01 91.37 TACHYCARDIA | 23 0.23 91.60 TACHYCARDIA PAROXYSMAL | 1 0.01 91.61 TACHYPHRENIA | 1 0.01 91.62 TACHYPNOEA | 4 0.04 91.66 TARDIVE DYSKINESIA | 9 0.09 91.75 TARSAL TUNNEL SYNDROME | 1 0.01 91.76 TEARFULNESS | 1 0.01 91.77 TEETH BRITTLE | 1 0.01 91.78 TELANGIECTASIA | 1 0.01 91.79 TEMPERATURE INTOLERANCE | 1 0.01 91.80 TEMPERATURE REGULATION DISORDER | 2 0.02 91.82 TEMPOROMANDIBULAR JOINT SYNDROME | 2 0.02 91.84 TENDERNESS | 2 0.02 91.86 TENDON DISORDER | 2 0.02 91.88 TENDON INJURY | 1 0.01 91.89 TENDON PAIN | 1 0.01 91.90 TENDON RUPTURE | 2 0.02 91.92 TENDONITIS | 2 0.02 91.94 TENOSYNOVITIS | 1 0.01 91.95 TENSION | 1 0.01 91.96 TENSION HEADACHE | 1 0.01 91.97 TERMINAL STATE | 1 0.01 91.98 TESTICULAR PAIN | 1 0.01 91.99 TESTIS CANCER | 1 0.01 92.00 TETANY | 1 0.01 92.01 THEFT | 1 0.01 92.02 THERAPEUTIC AGENT TOXICITY | 2 0.02 92.04 THERAPEUTIC RESPONSE DECREASED | 6 0.06 92.10 THERAPEUTIC RESPONSE UNEXPECTED | 2 0.02 92.12 THERAPEUTIC RESPONSE UNEXPECTED WITH .. | 1 0.01 92.13 THERAPY REGIMEN CHANGED | 1 0.01 92.14 THERMAL BURN | 2 0.02 92.16 THINKING ABNORMAL | 8 0.08 92.24 THIRST | 6 0.06 92.30 THIRST DECREASED | 1 0.01 92.31 THORACIC CAVITY DRAINAGE | 1 0.01 92.32 THORACIC VERTEBRAL FRACTURE | 1 0.01 92.33 THOUGHT BROADCASTING | 1 0.01 92.34 THROAT CANCER | 1 0.01 92.35 THROAT IRRITATION | 5 0.05 92.40 THROAT TIGHTNESS | 10 0.10 92.50 THROMBOCYTHAEMIA | 1 0.01 92.51 THROMBOCYTOPENIA | 40 0.40 92.91 THROMBOCYTOPENIC PURPURA | 2 0.02 92.93 THROMBOLYSIS | 1 0.01 92.94 THROMBOPHLEBITIS SUPERFICIAL | 1 0.01 92.95 THROMBOSIS | 9 0.09 93.04 THROMBOTIC MICROANGIOPATHY | 2 0.02 93.06 THROMBOTIC STROKE | 1 0.01 93.07 THROMBOTIC THROMBOCYTOPENIC PURPURA | 2 0.02 93.09 THYMUS ENLARGEMENT | 1 0.01 93.10 THYROID DISORDER | 2 0.02 93.12 THYROID FUNCTION TEST ABNORMAL | 3 0.03 93.15 THYROID NEOPLASM | 1 0.01 93.16 THYROIDITIS CHRONIC | 1 0.01 93.17 THYROXINE DECREASED | 1 0.01 93.18 TIBIA FRACTURE | 1 0.01 93.19 TINNITUS | 6 0.06 93.25 TOE AMPUTATION | 1 0.01 93.26 TONGUE BLACK HAIRY | 1 0.01 93.27 TONGUE COATED | 1 0.01 93.28 TONGUE DISORDER | 3 0.03 93.31 TONGUE INJURY | 1 0.01 93.32 TONGUE OEDEMA | 2 0.02 93.34 TONGUE PARALYSIS | 1 0.01 93.35 TONIC CLONIC MOVEMENTS | 1 0.01 93.36 TONSIL CANCER | 2 0.02 93.38 TONSILLAR DISORDER | 1 0.01 93.39 TOOTH DISCOLOURATION | 1 0.01 93.40 TOOTH DISORDER | 6 0.06 93.46 TOOTH EXTRACTION | 13 0.13 93.59 TOOTH FRACTURE | 2 0.02 93.61 TOOTH HYPOPLASIA | 1 0.01 93.62 TOOTH IMPACTED | 2 0.02 93.64 TOOTH INFECTION | 3 0.03 93.67 TOOTH INJURY | 1 0.01 93.68 TOOTH LOSS | 3 0.03 93.71 TOOTHACHE | 6 0.06 93.77 TORSADE DE POINTES | 7 0.07 93.84 TOXIC EPIDERMAL NECROLYSIS | 3 0.03 93.87 TOXIC INDUCED ENCEPHALOPATHY | 1 0.01 93.88 TOXIC SHOCK SYNDROME | 1 0.01 93.89 TOXIC SKIN ERUPTION | 3 0.03 93.92 TRACHEAL ULCER | 1 0.01 93.93 TRACHEOSTOMY | 2 0.02 93.95 TRACHEOSTOMY INFECTION | 1 0.01 93.96 TRANCE | 1 0.01 93.97 TRANSAMINASES INCREASED | 9 0.09 94.06 TRANSIENT ISCHAEMIC ATTACK | 8 0.08 94.14 TRANSIENT PSYCHOSIS | 1 0.01 94.15 TRANSMISSION OF DRUG VIA SEMEN | 2 0.02 94.17 TRANSPOSITION OF THE GREAT VESSELS | 1 0.01 94.18 TRAUMATIC BRAIN INJURY | 4 0.04 94.22 TRAUMATIC HAEMATOMA | 1 0.01 94.23 TREATMENT NONCOMPLIANCE | 5 0.05 94.28 TREMOR | 36 0.36 94.64 TRICUSPID VALVE INCOMPETENCE | 7 0.07 94.71 TRIGEMINAL NEURALGIA | 1 0.01 94.72 TRIGGER FINGER | 1 0.01 94.73 TRISMUS | 5 0.05 94.78 TRISOMY 18 | 1 0.01 94.79 TRISOMY 21 | 2 0.02 94.81 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM | 1 0.01 94.82 TUBERCULOSIS | 3 0.03 94.85 TUMOUR HAEMORRHAGE | 2 0.02 94.87 TUMOUR LYSIS SYNDROME | 2 0.02 94.89 TUMOUR MARKER INCREASED | 1 0.01 94.90 TYMPANIC MEMBRANE DISORDER | 3 0.03 94.93 ULCER | 1 0.01 94.94 ULNA FRACTURE | 1 0.01 94.95 UMBILICAL CORD ABNORMALITY | 1 0.01 94.96 UNDERWEIGHT | 2 0.02 94.98 UNEQUAL LIMB LENGTH | 1 0.01 94.99 UNEVALUABLE EVENT | 8 0.08 95.07 UNINTENDED PREGNANCY | 3 0.03 95.10 UNRESPONSIVE TO STIMULI | 9 0.09 95.19 UPPER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 95.20 UPPER LIMB FRACTURE | 3 0.03 95.23 UPPER RESPIRATORY TRACT INFECTION | 5 0.05 95.28 URETERIC OBSTRUCTION | 1 0.01 95.29 URINARY BLADDER ATROPHY | 1 0.01 95.30 URINARY BLADDER HAEMORRHAGE | 2 0.02 95.32 URINARY INCONTINENCE | 6 0.06 95.38 URINARY RETENTION | 6 0.06 95.44 URINARY TRACT DISORDER | 1 0.01 95.45 URINARY TRACT INFECTION | 13 0.13 95.58 URINARY TRACT OBSTRUCTION | 1 0.01 95.59 URINE COLOUR ABNORMAL | 1 0.01 95.60 URINE OUTPUT DECREASED | 2 0.02 95.62 URINOMA | 1 0.01 95.63 URTICARIA | 17 0.17 95.80 URTICARIA GENERALISED | 1 0.01 95.81 URTICARIA LOCALISED | 2 0.02 95.83 UTERINE CANCER | 1 0.01 95.84 UTERINE HAEMORRHAGE | 2 0.02 95.86 UTERINE HYPERTONUS | 1 0.01 95.87 UTERINE LEIOMYOMA | 1 0.01 95.88 UTERINE OPERATION | 1 0.01 95.89 UVEITIS | 4 0.04 95.93 VAGINAL CANDIDIASIS | 1 0.01 95.94 VAGINAL DISCHARGE | 1 0.01 95.95 VAGINAL HAEMORRHAGE | 3 0.03 95.98 VAGINAL INFECTION | 3 0.03 96.01 VANILLYL MANDELIC ACID URINE INCREASED | 1 0.01 96.02 VARICELLA | 1 0.01 96.03 VARICES OESOPHAGEAL | 3 0.03 96.06 VARICOSE VEIN | 1 0.01 96.07 VASCULAR BYPASS GRAFT | 1 0.01 96.08 VASCULAR ENCEPHALOPATHY | 1 0.01 96.09 VASCULAR INJURY | 1 0.01 96.10 VASCULAR OCCLUSION | 1 0.01 96.11 VASCULAR PURPURA | 2 0.02 96.13 VASCULITIS | 4 0.04 96.17 VASOCONSTRICTION | 1 0.01 96.18 VASODILATATION | 1 0.01 96.19 VEIN DISORDER | 1 0.01 96.20 VENA CAVA THROMBOSIS | 1 0.01 96.21 VENOOCCLUSIVE LIVER DISEASE | 1 0.01 96.22 VENOUS BRUIT | 1 0.01 96.23 VENOUS THROMBOSIS | 5 0.05 96.28 VENOUS THROMBOSIS LIMB | 1 0.01 96.29 VENTRICULAR EXTRASYSTOLES | 7 0.07 96.36 VENTRICULAR FIBRILLATION | 3 0.03 96.39 VENTRICULAR FLUTTER | 1 0.01 96.40 VENTRICULAR HYPERTROPHY | 4 0.04 96.44 VENTRICULAR SEPTAL DEFECT | 3 0.03 96.47 VENTRICULAR TACHYCARDIA | 11 0.11 96.58 VERTEBRAL INJURY | 1 0.01 96.59 VERTEBROPLASTY | 1 0.01 96.60 VERTIGO | 17 0.17 96.77 VERTIGO POSITIONAL | 1 0.01 96.78 VESTIBULAR DISORDER | 1 0.01 96.79 VIRAL INFECTION | 4 0.04 96.83 VIRAL PHARYNGITIS | 1 0.01 96.84 VISION BLURRED | 23 0.23 97.07 VISUAL ACUITY REDUCED | 15 0.15 97.22 VISUAL DISTURBANCE | 28 0.28 97.50 VISUAL FIELD DEFECT | 3 0.03 97.53 VITAMIN D DEFICIENCY | 1 0.01 97.54 VITREOUS DETACHMENT | 1 0.01 97.55 VITREOUS HAEMORRHAGE | 1 0.01 97.56 VOCAL CORD PARALYSIS | 1 0.01 97.57 VOGT-KOYANAGI-HARADA SYNDROME | 1 0.01 97.58 VOLVULUS | 2 0.02 97.60 VOMITING | 96 0.96 98.56 WEIGHT DECREASED | 37 0.37 98.93 WEIGHT INCREASED | 41 0.41 99.34 WHEEZING | 7 0.07 99.41 WHITE BLOOD CELL COUNT ABNORMAL | 1 0.01 99.42 WHITE BLOOD CELL COUNT DECREASED | 11 0.11 99.53 WHITE BLOOD CELL COUNT INCREASED | 18 0.18 99.71 WOUND | 1 0.01 99.72 WOUND COMPLICATION | 1 0.01 99.73 WOUND DEBRIDEMENT | 3 0.03 99.76 WOUND DEHISCENCE | 2 0.02 99.78 WOUND DRAINAGE | 1 0.01 99.79 WOUND HAEMORRHAGE | 1 0.01 99.80 WOUND SECRETION | 4 0.04 99.84 WRIST FRACTURE | 3 0.03 99.87 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 8 0.08 99.95 X-RAY ABNORMAL | 2 0.02 99.97 XEROSIS | 1 0.01 99.98 YAWNING | 1 0.01 99.99 YELLOW SKIN | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015